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GENERAL INTRODUCTION 
The large number of herpesviruses associated with a wide variety of 
diseases in man and other animals and their characteristics of latency and 
oncogenic potential have contributed to the interest in all members of this 
group. The bovine herpesviruses have been distinguished as being 
"associated with a diversity of clinical disease unparalleled by any other 
virus group affecting cattle" (Gibbs and Rweyemamu, 1977b). They have 
assumed increased importance in recent years due to their economic impact 
on the cattle industry. 
The recognized significance of bovine herpesviruses has led to 
extensive studies of immunization against these agents. These studies have 
included the use of modified live and inactivated virus vaccines. 
Inactivated virus preparations are recognized as protective, but many of 
' their other characteristics are unknown. 
Widespread infection of cattle with bovine herpesviruses, cross-
reactions between members of the group, extensive vaccination, and the 
inability to differentiate uninfected vaccinates from infected animals 
contribute to difficulties in virus-specific serodiagnosis. The identifi-
cation of those antigens destroyed by virus inactivation and of those 
antigens cross-reacting with other bovine herpesviruses is necessary before 
an antigen specific for live virus of a particular bovine herpesvirus 
species may be recognized. The identification of this antigen would allow 
the development of a virus-infection-specific serodiagnostic test. This 
would be invaluable in simultaneous vaccination-eradication efforts, 
2 
epidemiologic investigations, and certification of animals as free of 
particular diseases. 
The objectives of this study were (1) to determine the effects of 
common virus inactivation procedures on individual bovine herpesvirus 1 
(BHV 1) antigens, and (2) to identify those BHV 1 antigens which 
cross-react serologically with other bovine herpesviruses. BHV 1 
inactivation treatments studied included beta-propiolactone, formalin, 
heat, and ultraviolet irradiation. Infected-treated, infected-untreated, 
and uninfected-untreated cell preparations were solubilized using nonionic 
detergent. Individual BHVl antigens were then recognized and evaluated by 
testing these preparations alone and in combination by two-dimensional and 
fused rocket immunoelectrophoresis. This experimentation is described in 
the section entitled "The Effect of Some Common Inactivation Procedures on 
the Antigens of Bovine Herpesvirus l." Cross-reacting bovine herpesviruses 
studied included BHV 1, BHV 2, BHV 3, and suid herpesvirus 1. Infected and 
uninfected cell preparations were solubilized using a nonionic detergent. 
These preparations were tested alone and in combination by two-dimensional 
immunoelectrophoresis with homologous and heterologous antisera. This 
experimentation is described in the section entitled ''Cross-Reactions of 
Bovine Herpesvirus 1 Antigens with Those of Other Cattle Herpesviruses.'' 
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THESIS FORMAT 
This thesis consists of an introduction, a literature review, two 
separate manuscripts, a general summary, references and acknowledgments. 
The master's candidate, Randall Lynn Levings, is the senior author and 
principal investigator for each of the manuscripts. 
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LITERATURE REVIEW 
Herpesviruses 
The herpesviruses (Family Herpetoviridae) comprise a large group of 
viruses (over 100 members) which infect mammals, birds, reptiles, 
amphibians and bony fish. Organ systems affected include the integument 
and respiratory, gastrointestinal, lymphoid and nervous systems. 
The inclusion of many herpesviruses in the family is based on 
morphology as observed by electron microscopy (see Herpesvirions-
Structure). Three subfamilies of Herpetoviridae have been established on 
the basis of "host range, duration of reproductive cycle, cytopathology, 
and characteristics of latent infection" (Roizman et al., 1981). The 
alphaherpesvirinae (type species = human herpesvirus 1, herpes simplex 
virus 1) have a short replicative cycle an.d_ latent infections occur in 
ganglia. The betaherpesvirinae (type species = human herpesvirus 5, human 
cytomegalovirus) have a long replicative cycle and often cause enlargement 
of infected cells. The gammaherpesvirinae (type species = human 
herpesvirus 4, Epstein-Barr virus) replicate in lymphoblastoid cells (some 
also cause infections in epithelioid and fibroblastoid cells) and latent 
infection has been demonstrated in lymphoid tissue. The nomenclature of 
the herpesvir~ses has been variable. The system of Roizman et al. (1981) 
is used here. 
Herpesvirions are made up of three main components; nucleoid, capsid, 
and envelope. The virion enters the host by viral envelope adsorbtion 
onto, and fusion with, the host cell membrane. The nucleocapsid is then 
released into the cytoplasm, and a viral DNA-protein complex is 
5 
translocated into the nucleus. Viral DNA is transcribed in the nucleus, 
the mRNAs migrating to the cytoplasm for translation. The viral DNA is 
then replicated and nucleocapsids are formed, which bud through altered 
nuclear membrane and in some cases other membranes of the cell. Virions 
are released by transport to the cell surface through the modified 
endoplasmic reticulum. 
Many herpesviruses cause diseases of human and veterinary medical 
importance. Herpes simplex viruses 1 and 2 (human herpesviruses 1 and 2, 
HHV 1 and 2) are the agents of oral herpes, genital herpes (among the most 
common of sexually transmitted diseases), herpes keratitis (an important 
cause of blindness), encephalitis, and herpes neonatorum. Varicella-zoster 
virus (HHV 3) is the agent of chickenpox and zoster. Epstein-Barr virus 
(HHV 4) has been associated with infectious mononucleosis, Burkitt's 
lymphoma, and nasopharyngeal carcinoma. Human cytomegalovirus (HHV 5) 
usually causes inapparent infection in adults, but is a leading cause of 
birth defects. 
The herpesviruses of cattle and their associated diseases will be 
discussed in detail elsewhere (see Cattle Herpesviruses), but are briefly 
summarized here. Infectious bovine rhinotracheitis-infectious pustular 
vulvovaginitis virus (bovine herpesvirus l, BHV 1) is a cause of upper 
respiratory tract disease, reproductive tract disease, abortion, conjunc-
tivitis and calf encephalitis. Bovine mammillitis virus (BHV 2) is a cause 
of ulcerative mammillitis or generalized skin disease. Movar virus (BHV 3) 
infection is often inapparent, but may cause respiratory disease. 
Pseudorabies virus (suid herpesvirus 1, SHV 1) causes a fatal nervous 
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system disease in cattle. Malignant catarrhal fever virus (alcephaline 
herpesvirus 1) in cattle causes inflammation of the mucous membranes of the 
mouth, nose and eyes, and nervous system signs. 
In swine, pseudorabies virus (SHV 1) may cause respiratory and nervous 
system disease, and swine cytomegalovirus (SHV 2) is the agent of inclusion 
body rhinitis. In sheep, an association between a herpesvirus (sheep 
herpesvirus, caprine herpesvirus 1) and pulmonary adenomatosis 
("Jaagsiekte"), a transmissible lung neoplasm, was suggested (Mackay, 1969, 
Malmquist et al., 1972, Martin, 1976) but has more recently been discounted 
(Villiers and Verwoerd, 1980). Caprine herpesvirus 2 infects young goats 
resulting in respiratory and gastrointestinal disease. 
Equine rhinopneumonitis virus or equine abortion virus (equine herpes-
virus 1, EHV 1) causes respiratory disease or abortion in the sixth through 
eleventh month of gestation and a neurological syndrome in pregnant mares. 
Pharyngitis caused by EHV 2 has been reported in young foals. Equine 
coital exanthema virus (EHV 3) causes vesicular lesions of the vulva of the 
mare and the penis of the stallion, and is transmitted by coitus. 
Dog herpesvirus (canid herpesvirus 1) causes a fatal viremic disease in 
infant puppies; in adults it causes mild vaginitis or posthitis and occa-
sionally conjunctivitis. Feline rhinotracheitis virus (feline herpesvirus 
1, FHV 1) causes an upper respiratory infection and may cause glossitis, 
conjunctivitis, keratitis and abortion. Urolithiasis in experimentally-
infected cats has been associated with FHV 2. • 
Marek's disease virus (gallid herpesvirus 2) is the agent of an inflam-
matory and neoplastic disease of the nervous system and other organs of 
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chickens, turkeys, and other birds. The disease, also known as 
neurolymphomatosis or range paralysis, is manifested by flaccid or spastic 
paralysis of the leg, wing or neck due to nerve trunk involvement, by 
fading of the iris and irregularity of the pupil (ocular lymphomatosis) and 
by tumors in the gonad, liver, lung and skin. Avian infectious laryngo-
tracheitis virus (gallid herpesvirus 1) causes rhinitis, upper respiratory 
disease and conjunctivitis in chickens and pheasants, resulting in high 
mortality. Pigeon herpesvirus (columbid herpesvirus 1) causes coryza in 
pigeons. Duck virus enteritis, caused by anatid herpesvirus 1, is 
characterized by disease of the gastrointestinal, respiratory, and nervous 
systems. 
Channel catfish virus (ictalurid herpesvirus 1) causes a hemorrhagic, 
systemic infection in fry and fingerling channel catfish. 
Cattle Herpesviruses 
Bovine herpesvirus ..!. 
Bovine herpesvirus 1 is worldwide in distribution (Gibbs and Rweyemamu 
1977a) and is ubiquitous in the United States (Rosner, 1968, Sheffy and 
Krinsky, 1973, Kahrs, 1974). Cattle are the principal reservoir, although 
goats (Mohanty et al., 1972a), swine (Nelson et al., 1972) and other 
.species can be infected. Infectious bovine rhinotracheitis was described 
in feedlots in the western U.S. in 1955 by Miller (1955), and the 
associated herpesvirus (BHV 1) was isolated the following year (Madin et 
al., 1956), although serologic evidence shows the virus had been present in 
the U.S. much earlier. The virus was later associated with infectious 
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pustular vulvovaginitis (IPV, Kendrick et al., 1958, McKercher, 1963), so 
one common name for BHV 1 is IBR-IPV virus (Baker et al., 1960). ·Abortion 
(Lukas et al., 1963, McKercher and Wada, 1964) and other clinical effects 
of infection were subsequently described. 
Transmission is by direct contact, large quantities of virus being shed 
in respiratory, ocular, and reproductive secretions during primary infec-
tions and following reactivation of latent infections (Sheffy and Davies, 
1972, Sheffy and Rodman, 1973, Davies and Duncan, 1974). The incubation 
period varies from two to six days. Latency is a characteristic of herpes-
viruses and has been reported for BHV 1 infections involving a variety of 
clinical syndromes. BHV 1 DNA has been demonstrated in the trigeminal 
ganglia of intranasally-infected calves (Ackermann et al., 1982) and the 
sacral ganglia of intravaginally-infected calves (Ackermann and Wyler, 
1984) during the latent stage of infection. 
Although antigenic differences between BHV 1 isolates have been 
reported (Buening and Gratzek, 1967, House, 1972, Crandell, 1973, Potgieter 
and Mar€, 1974a), distinct antigenic groups have not been demonstrated 
(Ludwig, 1983). However, isolates from reproductive disease have been 
demonstrated to differ from isolates of other clinical manifestations by 
restriction enzyme analysis (Engels et al., 1980, 1981). Reviews of BHV 1 
literature include those written by McKercher (1959 and 1973), Gibbs and 
Rweyemamu (1977a), Kahrs (1977), and Ludwig (1983). 
Respiratory tract disease The respiratory disease associated with 
BHV 1 infection (!BR) is characterized by fever, depression, inappetance, 
and dyspnea. Catarrhal, progressing to mucopurulent, rhinitis may be 
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associated with hyperemia of the nasal turbinates and muzzle (''red nose") 
or foci of necrosis with adherent white material (''plaques") resulting from 
the coalescence of pustules (Studdert et al., 1964). This plaque material 
consists of leukocytes, fibrin and necrotic epithelial cells. Intranuclear 
inclusion bodies may be observed (Cr.andell et al., 1959). A severe 
generalized necrotic tracheitis with diphtheritic membrane ("sewer pipe 
trachea") may be seen. The case-fatality rate of IBR is 1 ow unless 
secondary bacterial infection occurs, e.g., pulmonic pasteurellosis or 
shipping fever. Catarrhal to mucopurulent conjunctivitis may accompany the 
respiratory disease (Ferris et al., 1964, McKercher and Wada, 1964). 
Abortion may also accompany respiratory disease, beginning in a herd while 
clinical signs are evident and continuing for 90-100 days. 
Conjunctivitis Conjunctivitis may accompany the respiratory 
manifestation of BHV 1, or it may be the principal clinical sign of the 
infection (Timoney and O'Connor, 1971, Rebhun et al., 1978). It may 
consist of inflammation of the conjunctiva, clear to mucopurulent ocular 
discharges, pustules or plaques of necrotic debris on the conjunctiva, and 
occasionally corneal opacity, which starts at the corneoscleral junction 
and proceeds centripetally. Abortion may accompany the conjunctiva] form 
of BHV 1 infection. 
Reproductive tract disease Infectious pustular vulvovaginitis, or 
Blaschenausschlag, caused by BHV 1, is manifested by pustules or white 
necrotic plaques on the vulvar and vaginal mucosa, and mucopurulent 
discharge. The disease is transmitted by natural breeding and sniffing 
cattle (Kahrs and Smith, 1965). The disease usually develops one to three 
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days after mating. IBR and IPV may, but do not usually, occur together. 
Bulls infected with BHV 1 through breeding.of cows with IPV infection may 
develop balanoposthitis with foci of necrosis (Kendrick and McEntee, 1967). 
These bulls may transmit the agent by natural breeding or by contamination 
of semen to be used for artificial insemination (Saxegaard, 1970, White and 
Snowdon, 1973, Schultz et al., 1976). Insemination of cows with BHV !-
contaminated semen may result in endometritis, shortened estrus periods 
(Kendrick and McEntee, 1967) and lower conception rates (Parsonson and 
Snowdon, 1975). 
Abortion and neonatal disease Abortion due to BHV 1 may be 
associated with any or none of the other clinical manifestations of 
infection. In field conditions, about 25% of pregnant cattle may abort in 
association with an outbreak; higher percentages are reported in experi-
mental circumstances (Owen et al., 1964). Although fetuses exposed in any 
stage of gestation may be aborted, most are in the third trimester (Owen et 
al., 1964, Kahrs et al., 1973). The exposure-abortion interval may range 
from eight days to several months, with abortions during the herd outbreak 
or up to 100 days afterward (Saunders et al., 1972, Wilson, 1974, Dellars, 
1975). Microscopic focal necrosis of liver, stomach, kidneys, and adrenal 
glands as well as intranuclear inclusion bodies may be observed in the 
aborted fetus; which may or may not be autolysed (Dellars, 1975). 
Infection in utero in late gestation or shortly after birth results in 
an acute febrile systemic disease of the newborn with high mortality (Baker 
et al., 1960, Reed et al., 1973). It may result in respiratory distress, 
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diarrhea, diffuse peritonitis, and white necrotic lesions on the mucosa of 
the mouth, tongue, esophagus and all four stomach compartments. 
Encephalomyelitis Infection of young cattle with BHV 1 may result 
in nonpurulent leptomeningitis and encephalitis (Barenfus et al., 1963). 
This is manifested by incoordination, circling or licking at the flanks 
(Beck, 1975), recumbency, and death (McKercher et al., 1970). Gross 
lesions are not remarkable. Histologic lesions are most severe in the 
cerebrum, thalamus and basal ganglia. Lymphocytic meningitis and 
perivascular cuffing with mononuclear cells are the principle lesions. 
Other clinical syndromes Bovine mastitis has been experimentally 
produced by udder inoculation of BHV 1 (Greig and Bannister, 1965), and the 
virus has been isolated from mastitis cases (Roberts and Carter, 1974, 
Gourlay et al., 1974). One report exists of BHV 1 isolation from perineal 
skin of chronic dermatitis cases in bulls (Bwangamoi and Kaminjolo, 1971). 
Bovine herpesvirus _£ 
BHV 2, originally isolated by Alexander et al. in 1957, has been 
reported in North America, Europe, Africa and Australia (Gibbs and 
Rweyemamu, 1977b), and is the cause of nonfatal diseases with various 
clinical signs and names in those regions. The bovine dermotrophic viruses 
of the United States, the virus causing bovine herpes mammillitis, ulcera-
tive mammillitis and skin gangrene of the udder in the United Kingdom, and 
the "Allerton virus" causing pseudo l umpyskirl disease in South Africa are 
believed to belong to the same species (Gigstad et al., 1971, Dardiri, 
1973, Cilli and Castrucci, 1976, Gibbs and Rweyemamu, 1977b, Gigstad and 
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Stone, 1977), although minor antigenic differences have been noted between 
strains (Castrucci et al., 1979}. 
Cattle are considered the natural reservoir although wild herbivores in 
Africa can apparently be infected (Gibbs and Rweyemamu, 1977b). The method 
of transmission is not definitely known, but insect vectors and milking 
have been suggested (Gilli and Castrucci, 1976}. The incubation period is 
two to ten days. Martin et al. (1975) demonstrated persistent infection 
with BHV 2 and recrudescence following corticosteroid injections. Although 
some infections may be inapparent (Dardiri and Stone, 1972), pyrexia may be 
present and edema, vescicles, ulcers and scabs or poxlike lesions may occur 
on infected teats and udders, with mastitis as a frequent sequel (Martin et 
al., 1966). Reduced milk production is observed in affected herds. The 
uncomplicated disease is self-limiting, and lesions resolve in several 
weeks (Gibbs and Rweyemamu, 1977b). Calves nursing affected cows may 
develop oral or muzzle ulcers. The generalized skin disease described in 
South Africa is characterized by pyrexia and firm round nodules most 
prevalent on the head, neck, back and perineum (pseudolumpyskin disease). 
This may, but usually does not, occur with udder infection. Epidermal 
lesions consist of intracellular edema in the stratum germinativum and 
stratum spinosum, infiltration of mononuclear and polymorphonuclear cells, 
and formation' of syncytia with intranuclear inclusion bodies. 
The literature concerning this virus has been reviewed by Martin 
(1973), Gilli and Castrucci (1976), Gibbs and Rweyemamu (1977b), and Ludwig 
(1983). 
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Bovine herpesvirus l 
BHV 3 strains have been isolated from a variety of clinical syndromes 
and from clinically normal cattle in North America, Europe and Africa 
(Gibbs and Rweyemamu, 1977b). In most cases, experimental inoculation with 
the agents has failed to elicit disease, although inoculation into the 
nose and trachea of calves has resulted in fever, respiratory disease and 
conjunctivitis in a few instances (Bodon et al., 1971, Mohanty et al., 
1972b, Mohanty, 1973). Virus has been reisolated from the thoracic lymph 
node, spinal cord and trigeminal ganglion of corticosteroid-treated, 
experimentally infected cattle (Krogman, 1980) and the trigeminal ganglia 
of slaughtered cattle (Homan and Easterday, 1980). Evidence has been 
presented for a lymphoid-associated persistent virus infection in cattle 
(Osorio and Reed, 1983). The literature concerning this virus has been 
reviewed by Gibbs and Rweyemamu (1977b), Mohanty (1980), and Ludwig (1983). 
Suid herpesvirus ..!. 
SHV 1 is the etiologic agent of Aujesky's disease or pseudorabies, 
which is usually considered a disease of swine, its reservoir host (Shope, 
1935). In swine latent, subclinical, or clinical infections may occur, 
with syndromes including abortion or acute death in baby pigs •. Cattle and 
other dead-end hosts are infected by the bite or nasal discharge of 
infected swine. In cattle, the disease has been called "Mad Itch.'' 
Intense pruritis leading to self-mutilation is frequently observed, with 
the hindlimbs and vulva most frequently involved, though other areas may be 
affected (perhaps reflecting different sites of inoculation). Fever, rapid 
respiration and behavioral changes, leading to convulsions, recumbency and 
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death are often observed. The lymphocytic infiltration of the peripheral 
nerves supplying the affected area support.the neurogenic origin of the 
self-mutilation. In the central nervous system, a nonsuppurative 
encephalomyelitis, meningitis and ganglioneuritis may be seen, with intra-
nuclear inclusion bodies present. The literature concerning this virus has 
been reviewed by Baskerville et al. (1973), McKercher (1973) and Gustafson 
(1981). 
Alcelaphine herpesviruses ..!. and~ 
Alcelaphine herpesviruses 1 and 2 are the etiologic agents of African 
malignant catarrhal fever (MCF or snotsiekte in South Africa) and MCF-like 
disease, the reservoirs and asymptomatic carriers of which are the blue and 
black wildebeest and the hartebeest, respectively. Sheep-associated or 
American MCF may also be caused by one of these agents, but this has not 
been confirmed. The diseases are very similar in clinical and pathologic 
respects (Plowright, 1968), and so will be discussed together. MCF occurs 
worldwide, and is a highly fatal pansystemic disease characterized by 
mucosal lesions, a severe rhinitis, panopthalmia, lymphadenopathy, 
encephalitis, and often diarrhea. Transmission may occur from the 
reservoir host by ingestion of contaminated secretions and excretions 
(Plowright, 1~68, Storz et al., 1976). Cow-to-cow transmission is believed 
not to occur. Clinically inapparent infection in the wildebeest with 
induction of virus excretion by betamethasone has been reported (Rweyemamu 
et al., 1974). There is evidence of a latent infection in the bovine 
lymphocyte (Patel and Edington, 1981). 
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Fever, depression, photophobia and conjunctivitis with excess 
lacrimation may be early signs. Severe panopthalmitis, including corneal 
opacity progressing centrally from the limbus, may follow. The nasal 
discharge is mucopurulent, and the nasal mucosa may be crusted, hyperemic 
and necrotic. A diphtheritic membrane on the trachea may occur. Hyperemia 
and ulceration of the entire gastrointestinal tract may be noted. Raised 
skin lesions may slough or scab in hairless areas and coronary band lesions 
may be observed. White foci are noted in the kidney cortex. The brain and 
meninges may be edematous, and neurologic signs may be seen. Necrotizing 
vasculitis is characteristic histologically. 
The literature on MCF has been reviewed by Plowright (1968) and Mare 
(1977). 
Other cattle herpesviruses 
A herpesvirus has been isolated from the reproductive tissues of cattle 
with "Epivag Syndrome" (Epididymitis-vaginitis, Mare and Van Resnburg, 
1961, Theodoridis, 1978). Because many enlarged cells were produced in 
tissue cultures infected with the virus, it has been described as a bovine 
cytomegalovirus {Mohanty, 1980). 
A virus of herpesvirus structure was isolated by Van Der Maaten and 
Boothe {1972) .from the lymphocytes of two cattle with lymphosarcoma. The 
virus was strongly cell-associated and caused syncytia is tissue culture, 
but intranuclear inclusion bodies were not observed. Calves infected with 
the agent manifested no clinical signs, but the virus was reisolated from 
the circulating leukocytes of these calves 4-12 months post-inoculation. 
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Herpesvirions 
Structure 
The herpesvirion (120-200nm diameter) consists of three major 
components; the core, the capsid, and the envelope. The core or nucleoid 
is found inside the capsid, and in HHV 1 is an electron-dense toroid 
structure 50nm high, with an outside diameter of 70nm and an inside 
diameter of 18nm (Furlong et al., 1972). It was proposed that the core is 
composed of a cylindrical protein structure around which the DNA is wound 
with a spacing of 4-5nm. The herpesvirus DNA is a linear, double-stranded 
molecule of 80-150 megadaltons, 32-75% G+C. The structures of herpesvirus 
DNAs have been reviewed by Gentry and Randall (1973) and Roizman and 
Furlong (1974). Between the core and capsid lies the pericore (Roizman and 
Furlong, 1974), which may contain proteins that interact with both core and 
caps id. 
The icosahedral capsid is approximately lOOnm in diameter, and is made 
up of 162 capsomers, including 150 hexagonal and 12 pentagonal units (Wildy 
et al., 1960). The hexamers measure 8-10.2nm in diameter and 12.5nm in 
length, with a 4nm diameter hole halfway through the long axis (Roizman and 
Spear, 1973). The tegument is a layer of material which lies between the 
capsid and envelope (Roizman and Furlong, 1974). 
The envelope is a bi-layered nonrigid membrane which is structurally 
similar to a cellular nuclear membrane (Epstein, 1962) and may occasionally 
bear projections 8-lOnm long and spaced 5nm apart (Wildy et al., 1960, 
Watson, 1973). 
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The bouyant density (CsCl) of the particle is 1.20-1.29 g/cm3 and the 
virion is sensitive to lipid solvents. 
This subject has been reviewed by Wildy et al. (1960), Gentry and 
Randall (1973), and O'Callaghan and Randall (1976). 
Antigen analysis 
Virus antigens can be analyzed by immunological, biochemical, and 
combined methods. These may be applied to isolated elements of the virion, 
whole virion, or infected cells to yield a variety of information. 
Immunological The immunological techniques include virus 
neutralization (VN), virus sensitization, complement fixation (CF), immuno-
diffusion (ID), immunoagglutination, and the use of labeled antibodies, 
including immunofluorescence (IF), immunoperoxidase (IP), immunoenzyme, and 
radioimmunoassays (RIA). Virus neutralization may be used to distinguish 
antigenic differences between herpesvirus strains, either by differences in 
titers or in neutralization kinetics. This technique can also be extended 
to the use of inactivated virus antigen preparations to inhibit the 
neutralization of a known live virus preparation. Virus sensitization 
exploits the ability of nonneutralizing antibodies to lead to virus 
neutralization by antiglobulin, complement, or Staph A. Complement fixa-
tion makes use of the ability of an antigen-antibody complex to tie up 
complement. The most common immunodiffusion techniques employ immuno-
precipitation in agar gels, including radial immunodiffusion and double 
immunodiffusion. One limitation of these techniques is that only 
precipitating antigen-antibody complexes are detectable. Other immuno-
diffusion techniques include radial immune hemolysis. Immune agglutination 
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techniques include HA and HI for a few herpesviruses (including EHV 1), 
passive hemagglutination, and agglutination of antigen-bearing latex 
particles. 
The use of labeled antibodies has dramatically increased recently due 
to their sensitivity and specificity. Direct, indirect, double antibody 
sandwich, competitive, biotin-avidin, and combinations of these with 
antibody-antibody or antibody-label complexes have found use in antigen 
identification, quantitation and localization. 
In vitro techniques using elements of the cell mediated immune sub-
system include lymphocyte activation, cytotoxicity, and other assays. In 
vivo immune phenomena employed include immediate hypersensitivity, delayed 
hypersensitivity, and active and passive immunization. Immunological 
analyses are reviewed by Van Regenmortel (1981). 
Biochemical/biophysical The biochemical and biophysical techniques 
used include electron microscopy, the use of various disrupting and 
labeling agents, chromatograpy, electrophoresis, peptide analysis, and 
amino acid sequencing. Electron microscopy allows visualization and 
localization of the antigens of virions and virus-infected cells, but may 
not allow identification. Treatment of virions with nonionic detergents, 
freezing and thawing, osmotic shock, chaotropic agents, proteolytic 
enzymes, non-penetrating dyes, and labeling with Il25 by the lactoperox-
idase reaction may aid in the identification of envelope antigens. The 
interuption of viral infection in vitro (e.g., with Actinomycin D) allows 
isolation of early vs. late viral proteins. The use of chromatography 
allows identification, characterization, and purification of antigens. 
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Molecules may be separated according to size, affinity for certain 
compounds (e.g., lectins) or according to their ionic character (e.g., 
anion exchange, cation exchange). 
Electrophoresis of proteins may be done on paper, cellulose acetate, or 
polyacrylamide gels. These can in turn be stained or used for autoradio-
graphy if the preparation is labeled with radioisotope-labeled amino acids. 
By producing the virus preparation in the presence of specific labeled 
precursors (e.g., c14 glucosamine), further information may be obtained. 
Electrofocusing can be used for identification and purification of protein 
antigens, and this technique may be combined with polyacrylamide gel 
electrophoresis (PAGE) for increased resolution. 
Peptide analysis and amino acid sequencing of viral proteins is not yet 
commonly utilized for herpesviruses, as it is for some other groups (e.g., 
some members of the picornaviridae). The biochemical/biophysical methods 
are reviewed by O'Callaghan and Randall (1976), Altstein and Zhdanov 
(1979), Lauffer (1981), and Fraenkel-Conrat (1981). 
Combination The combinations of the two categories discussed above 
are obviously many, but some of the more commonly used include immune 
electron microscopy, immune affinity chromatography, and immunoelectro-
phoresis. Immune electron microscopy can be used on tissues (using the 
antibodies linked to ferritin or peroxidase as a stain) and on antigens in 
suspension. The applications of the latter include precipitation, 
decoration, trapping, and combinations thereof. Immune affinity 
chromatography involves passing a mixture containing the unknown antigen or 
antibody through a column with known antibody or antigen bound to inert 
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substrate. By testing the unbound fraction, or eluting and testing the 
bound fraction, purification and identification of antigens is possible. 
Immunoelectrophoresis techniques are used to identify and quantify 
viral antigens. Modifications of the original agar gel technique include 
counterimmunoelectrophoresis, in which the antigen and antibody prepara-
tions migrate toward each other (at pH 7.0-8.0), rocket immunoelectro-
phoresis, in which the antigen migrates under an electrical potential into 
a field of antibody, line immunoelectrophoresis, similar to rocket, except 
the antigen migrates from a trough or horizontal gel instead of a well, and 
crossed or two-dimensional immunoelectrophoresis. The latter technique has 
been found to yield higher resolution than classic immunoelectrop.horesis 
and allows quantitation and greater fine tuning of identification through 
its numerous modifications. These include tandem crossed, addition of 
antigen or antibody, inclusion of lectin, antigen or antibody in inter-
mediate gel, as well as others. 
The literature concerning this subject has been reviewed by 
Van Regenmortel {1981) and Axelson and Bock (1972). 
Proteins and antigens 
Structural Studies using PAGE of highly purified HHV 1 have 
revealed 33 polypeptides ranging in size from 25,000 to 275,000 daltons 
{Heine et al., 1974, Roizman and Furlong, 1974). The major capsid protein 
was approximately 150,000 daltons. Empty capsids revealed four structural 
polypeptides {Gibson and Roizman, 1972, 1974, Roizman and Furlong, 1974), 
with a 47,000 dalton protein associated with the core. At least 13 
glycoproteins were observed in the virions and are thought to be confined 
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to the envelope. Structural (and perhaps non-structural) glycoproteins are 
inserted in the cellular membranes of infected cells (Ben~Porat and Kaplan, 
1973, Spear and Roizman, 1970, Heine et al., 1972, Heine and Roizman, 
1973). Thus, the glycoproteins may be important in such phenomena as viral 
attachment and antigenicity, and the behavior of infected cells, including 
oncogenicity (Tevethia et al., 1972, Levitan and Blough, 1975, Nahmias and 
Roizman, 1973, Duff and Rapp, 197la,b). The protein moiety is inserted 
into that section of membrane being modified for budding through and 
glycosylation occurs.!.!!_ situ (Ben-Porat and Kaplan, 1973, Spear and 
Roizman, 1970) with at least six constituents present; glucosamine, 
galactosamine, fucose, mannose, sialic acid, and galactose (Roizman and 
Furlong, 1974). Virus particles, but not infectious virions, are produced 
in the presence of 2-deoxyglucose, an inhibitor of glycosylation (Courtney 
et al., 1973, Ludwig et al., 1974). 
Similar results in number and sizes of polypeptides, including the 
major capsid protein, were obtained in studies of other herpesviruses using 
similar techniques. Studies of BHV 1 have revealed 18 polypeptides, 
29,000-250,000 MW, 8 glycosylated (Sklyanskaya et al., 1977); 21 
polypeptides, 31,000-275,000 MW, 10 glycosylated (Pastoret et al., 1980); 
25-33 polypeptides, 12,000-330!000 MW, 11 glycosylated (Misra et al., 
1981); and 33 polypeptides, 13,000-275,000 MW (Bolton et al., 1983). 
Dolyniuk et al. (1976) demonstrated 33 polypeptides in the virions of HHV 
4. Work on EHV 1 revealed 20 (Abodeely et al., 1971, Killington et al., 
1977) to 28 (Perdue et al., 1974, Kemp et al., 1974) structural proteins 
ranging from 16,000 to 276,000 daltons. Studies on mouse cytomegalovirus 
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demonstrated 26 polypeptides, while SHV 1 is reported to contain 20 
(Stevely, 1975, Killington et al., 1977). 
Nonstructural Forty-nine viral-specific proteins, ranging in 
molecular weight from 15,000 to 280,000, have been detected in HHV 1-
infected human cells, at least 16 of these being nonstructural (Honess and 
Roizman, 1973). Fifty-one proteins were observed in HHV 2-infected cells, 
of molecular weight 20,000 to 281,000 (Powell and Courtney, 1975). These 
proteins were grouped into a, a and y groups, reflecting an interlocking 
cascade of viral protein synthesis phases (Honess and Roizman, 1974, 1975). 
The a group seems to consist of nonstructural proteins, and most a proteins 
are nonstructural as well. Some of the nonstructural proteins have been 
associated with virus-specific enzymes (Dubbs and Kit, 1964, Powell and 
Purifoy, 1977), and one HHV 2-induced polypeptide has been detected in HHV 
2-transformed cell lines (Flannery et al., 1977). Antisera against HHV 
1-infected cells have been shown· to inhibit viral enzyme activities in 
infected cell extracts (Klemperer et al., 1967, Keir et al., 1966). In 
addition to the 25-33 structural proteins detected in BHV 1, 15 nonstruc-
tural proteins were noted in BHV I-infected cells (Misra et al., 1981). 
Inactivation 
Although many physical and chemical treatments have been shown to 
inactivate herpesviruses, those receiving the most study have been heat, 
ultraviolet irradiation, photodynamic methods, formaldehyde and beta-
propiolactone because of their straightforward nature, the ability to vary 
the treatment dose, and the possibility of genome survival in spite of loss 
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of lytic infection capability. The problem of genome survival takes on 
added significance considering the oncogenic potential of herpesviruses. 
A biphasic curve of inactivation (i.e., beginning with a plateau or lag 
phase) of HHV 1 at 37°C has been reported {Kaplan, 1957, Hoggan and 
Roizman, 1959) and was confirmed for HHV 1 and 5 {Plummer and Lewis, 1965). 
HHV 1 physical integrity and ability to absorb to mammalian cells were 
unaffected by 36°C inactivation (Lancz, 1980). Infectivity of HHV 1 and 2 
inactivated by heating at 56°C was revealed when cell entry was enhanced by 
Ca-DMSO ("transfection," Fenyves, 1982). Inactivation of HHV 1 and 2 at 
56°C effectively destroyed transforming ability, with lower temperatures 
being less effective (Rapp and Turner, 1978). 
UV-inactivated HHV 1 was shown to produce smaller plaques in tissue 
culture than unirradiated virus. Pyrimidine dimers and the delay involved 
in repair was suggested to account for this phenomenon (Ross et al., 
1972a). Irradiated virus adsorbs to and penetrates cells as efficiently as 
unirradiated virus. UV-inactivated HHV 1 was shown to undergo host cell 
reactivation and multiplicity reactivation (Ross et al., 1972a, Roubal and 
Vonka, 1973), as expected if pyrimidine dimers underlie the inactivation. 
Oncogenic transformation by UV-inactivated HHV 1 has been observed in vitro 
(Duff and Rapp, 197lb). 
It has been suggested that photodynamic treatment of HHV 1 prevents 
virus maturation {Khan et al., 1977). Cervical carcinomas were observed in 
mice following vaginal application of formalin-inactivated HHV 2 {Wentz et 
al., 1975). SV-40 or polyoma virus was shown to be capable of trans-
24 
formation or tumor formation, respectively, following beta-propiolactone 
inactivation (Brown et al., 1974, Seemayer.and Defendi, 1974). 
Immunologic Relationships Among the Herpesviruses 
The immunologic relationships between the members of the herpesvirus 
group have been investigated by a variety of techniques. These investi-
gations have been undertaken for many reasons, including proof of non-
identity, construction of taxa, identification of structural elements 
common to herpesviruses, and identification of type-specific antigens to 
aid diagnosis. 
Figure 1 represents a selection of the.positive and negative cross-
reaction results reported for herpesviruses. In each case, the homologous 
system yielded a positive result. No attempt has been made to explore the 
intricacies of each test system or the possible interpretations of the 
myriad of results. This subject has been reviewed by Plummer (1964) and 
Honess and Watson (1977). 
Figure 1: Irmiunologic relationships of herpesviruses 
Ag =Antigen preparation; IR = Immune response to virus 
HV = Herpesvirus; H = Human; NHP = Nonhuman primate; B = Bovine; A = Alcelaphine; Cp Caprid; 
S = Suid; E = Equid; Cn = Canid; F = Felid 
N Virus neutralization; F = Immunofluorescence; C = Complement fixation; 
D Immunodiffusion; E = Immunoelectrophoresis; X =Other technique 
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Additional Information 
N = Hyperi1T1J1unizing BHV l-N+ cattle with SHVl increased titers to both 
X Delayed-type hypersensitivity reactions to BHV 1 and SHV 1 were similar in BHV 1-N+ cattle 
X = Counter-ilTllluno-electro-osmophoresis 
X = Protection against SHV 1 in cattle with BHV 1 
NHPHV = Saimiriine herpesvirus 2 (Squirrel monkey herpesvirus) 
X = decrease in clinical signs and virus titer upon BHV 2 intravenous or intradermal challenge 
in cattle 
NHPPHV = Saimiriine herpesvirus 2; X = counterelectrophoresis 
NHPHV = Cercopithecine herpesvirus 1 (B virus); HHV 1 = 11 HSV 11 -no further identification given 
F = direct and indirect 
HHV 1 = 11 HSV"-no further identification given; BHV 2 = "a bovine teat virus" 
X = Immunoprecipitation polyacrylamide gel electrophoresis (IPPAGE) 
NHPHV = Cercopithecine herpesvirus 1 
F = Indirect; X virion agglutination 
X = decrease in clinical signs upon HHV 1 challenge in mice 
NHPHV = Cercopithecine herpesvirus 1 
X ELISA 
X = IPPAGE; All tests with antiserum against a major ONA-binding protein of HHV 2 
~ HHV1 HHV 2 HHV 3 HHV 4 NHPHV BHV 1 BHV 2 BHV 3 AHV 1 CpHV 1 SHV 1 EHV 1 EHV 2 EHV 3 CnHV 1 FHV 1 FHV 2 
Aa 
HHV1-
+IBND.24N +130€X -·,23N +9NF,t3D +18NO +18D,26FX +9F,33X +<N ~ 31NO -9N.23NC 27NFCX +33X-18N -9N,18NO 
26F,33FllX -32NFCX -9N 27NC -23N.27NC 23NC -'z.!NC -16N 
+1BND,24N //////, +18N +t80,27NF +180,26F +33X 
HHV 2 - //////, 33X 33)( -'l1 -18N -18ND 
HHV 3 ~ -3'NFCX 
+26F +26F ~ +13DE +26F HHV 4 
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-23NC -23N -23N -23N 23NC,29N ?//,/,;, 29N -10F 
+15NFCD •,;////, 
EHV 3 -15NCD, ~ -15N,29N 29N -10F ..... ~ CnHV 1 -28N -28N -28N 
FHV 1 ~ 
FHV 2 
-1Qf.1'NF ~ -14N -14" -14NF -14" -14NF -14N 
27 
PART I. THE EFFECT OF SOME COMMON INACTIVATION PROCEDURES ON 
THE ANTIGENS OF BOVINE HERPESVIRUS 1 
This manuscript has been submitted to Veterinary Microbiology. 
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ABSTRACT 
Bovine embryonic kidney cells were infected with bovine herpesvirus 1 
(BHV 1) or were sham-inoculated. When cytopathic effect was apparent, the 
cells were treated with beta-propiolactone, formalin, heat (56°C), or 
ultraviolet irradiation until the virus was inactivated. Infected-treated, 
infected-untreated (IU), and sham-inoculated cultures were solubilized 
using Triton X-100 detergent. Resulting preparations were tested by 
two-dimensional and fused rocket immunoelectrophoresis and were evaluated 
for their ability to inhibit virus neutralization by BHV 1 antiserum. 
Eleven viral antigens were detected consistently in IU preparations, 
which strongly inhibited virus neutralization. Eight or more IU antigens 
were detected in beta-propiolactone-treated, formalin-treated, and 
heat-treated preparations; these inhibited virus neutralization less 
strongl·y than the IU preparations. No IU antigens were detected in 
ultraviolet-treated preparations, nor did this material inhibit virus 
neutralization. One of the IU antigens was reduced preferentially by all 
treatments. The selective destruction of antigens by the various 
treatments might allow antigen-specific serologic testing to distinguish 
vaccinated from naturally-exposed cattle. 
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INTRODUCTION 
A variety of chemical and physical treatments, including 
beta-propiolactone (BPL), formalin, heat, and ultraviolet (UV) irradiation 
is used to inactivate viruses. Inactivated virus is often used for viral 
characterization,_!..!!. vitro immunologic tests, and preparation of vaccines 
because many treatments eliminate infectivity, but not antigenicity or 
other characteristics. 
The immunogenicity of inactivated bovine herpesvirus 1 (BHV 1) has been 
studied extensively in cattle. Formalin-inactivated (Schipper and Kelling, 
1975) and nonionic detergent-solubilized (Lupton and Reed, 1980) BHV 1 
vaccines without adjuvant lacked efficacy as measured by induction of virus 
neutralizing (VN) antibodies. However, vaccination of cattle with two 
doses of adjuvanted BHV 1 which had been inactivated with formalin 
(Matsuoka et al., 1972), nonionic detergent (Lupton and Reed, 1980), 
ethanol (Haralambiev, 1976), and heat or UV (Hristov and Karadjov, 1975) 
induced production of VN antibodies. In these studies, formalin or 
nonionic detergent-inactivated (parenteral) vaccines protected cattle from 
virulent BHV 1 intranasal challenge. Ethanol-inactivated vaccine was 
injected into the nasal submucosa and also had protective activity. 
Among the.herpesviruses, herpes simplex viruses 1 and 2 (human herpes-
viruses 1 and 2, HHV 1 and 2) have received the most extensive study 
relative to viral properties following inactivation. Inhibition of serum 
neutralization of HHV 1 by nonionic detergent-solubilized HHV I-infected 
cell cultures was unchanged by formalin treatment, but was reduced by 
temperatures greater than 44°C for 1 hour (Kutinova et al., 1977). Lancz 
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(1980) demonstrated that HHV 1 inactivated by heating at 36°C retained 
gross physical integrity and mammalian cell adsorbtion activity. This 
relative stability of adsorptive activity also was demonstrated for HHV 1 
by transformation assays of virus preparations inactivated by heat and UV 
(Rapp and Turner, 1978). Exposure of cell cultures to virus preparations 
inactivated by limited treatment resulted in transformation. The 
transformed cell cultures were virus-free, but expressed viral antigens. 
However, more rigorous treatment eliminated transformation activity. 
Equine herpesvirus 1 inactivated by combined BPL and UV treatment was 
reported by Campbell et al. (1982) to stimulate a secondary serological 
response in horses as measured by VN, but not a primary response in mice or 
rabbi ts. 
Detergent-solubilized virus preparations have been used to enumerate 
and partially characterize the antigens of several herpesviruses. 
Sklyanskaya et al. (1977), using polyacrylamide gel electrophoresis (PAGE), 
detected 18 polypeptides (8 glycosylated) in BHVl. Using PAGE with sodium 
dodecyl sulfate (SDS-PAGE), Pastoret et al. (1980) reported 21 polypeptides 
(10 glycosylated) in BHV 1, Misra et al. (1981) reported 25 to 33 poly-
peptides (11 glycosylated) in BHV 1 and 15 nonvirion polypeptides in BHV 1-
infected cells, and Bolton et al. (1983) reported 33 polypeptides in BHV 1. 
The reports concerning BHV 1 are comparable to the report of 33 
polypeptides in HHV 1 (13 glycosylated) by Heine et al. (1974). Eleven 
precipitating antigens (4 glycosylated) were detected in HHV 1- and 
2-infected cell cultures by two-dimensional immunoelectrophoresis (2DIE) 
(Vestergaard, 1973), Twenty precipitating antigens (8 glycosylated) were 
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detected in cell cultures infected with suid herpesvirus 1 (SHV 1) using 
this technique (Platt, 1982). 
The development and testing of inactivated vaccines, as well as the 
evaluation of host animal immunologic responses, is dependent on the 
identification of viral antigens and the effect of common inactivation 
procedures. Identification and.:!..!!_ vitro measurement of the protective 
antigen(s) would permit inactivation procedures to be optimized for vaccine 
production and would aid immunogenicity testing of the final product. If 
any antigen is selectively reduced or eliminated by inactivation, antigen-
specific serologic testing might distinguish vaccinated from naturally-
exposed host animals. 
Some effects of BHVl inactivation by BPL, formalin, heat, and UV were 
examined in this study. Effects on individual antigens were measured by 
2DIE and fused rocket immunoelectrophoresis (FRIE) of treated and untreated 
BHV !-infected cell cultures which had been solubilized by nonionic 
detergent. Effects on immunogenicity were measured by plaque reduction 
serum neutralization inhibition tests (PRSNIT) of these solubilized 
preparations. 
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MATERIALS AND METHODS 
Virus 
BHV 1 (Cooper strain) of low and high cell passage was used in this 
study. Low cell-passage viruses were standard NVSL BHV 1 challenge viruses 
and elicited signs of BHV 1 infection in calves exposed intranasally. High 
cell-passage BHV 1 was provided by Dr. G. L. Seawright, Los Alamos 
Scientific Laboratory (LASL), Los Alamos, New Mexico. 
Cell Cultures 
Cultures of third to fifth passage embryonic bovine kidney cells (EBK) 
were grown to confluency in 490 cm2 roller bottles (Corning Glass Works, 
Corning, NY) using Eagle's minimum essential medium (EMEM) with Earle's 
salts (Grand Island Biological Company, Grand Island, NY), 10% bovine fetal 
serum, 1% L-glutamine, 0.1 mg/ml streptomycin sulfate, and 0.025 U/ml 
penicillin G potassium. 
Virus Propagation and Inactivation 
Cultures to be infected were inoculated using 5 to 12 ml/bottle of a 
suspension of BHV 1 (multiplicity of infection between 1 and 4) in EMEM, 
with 1% L-glutamine, 0.05 mg/ml gentamicin sulfate and 0.0025 mg/ml 
amphotericin ~· Sham-inoculated (SI) cultures were inoculated with 
suspension medium only. After 60 to 90 minutes at 37°C, 0 to 7 ml/bottle 
of additional serum-free medium was added. When the cytopathic effect in 
the infected cultures reached 50 to 90% (16 to 32 hours), cells and 
supernatant fluids were harvested. Aliquots of the harvested suspensions 
were used immediately for treatment or stored at 4°C. 
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The BPL inactivation was effected by adding a 10% solution of BPL 
(Sigma Chemical Company, St. Louis, MO) to·a final concentration of 0.2%, 
followed by the addition of 1 N NaOH to a final concentration of 0.02 N. 
Inactivation was allowed to proceed for 72 hours at 37°C in a container 
with a loose cap. Formalin inactivation was accomplished by adding 
formalin solution (37% formaldehyde, Mallinckrodt, St. Louis, MO) to a 
final concentration of 0.1% formaldehyde, stirring the suspension for 72 
hours at room temperature, and adding 35% sodium bisulfite to a final 
concentration of 0.035%. Heat inactivation was effected by placement in a 
56°C water bath for 60 minutes, with stirring at 15-minute intervals. The 
UV inactivation was accomplished by exposure to a Westinghouse Sterilamp 
782L-30 bulb for 8 to 12 hours at an average dose of 10,000 to 15,000 
ergs/sec/mm2 as measured by a Blak-Ray ultraviolet intensity meter (Ultra-
Violet Products, San Gabriel, CA) while constantly stirring in two 150 x 25 
mm plastic tissue culture dishes (~35 ml/dish). 
Following treatment, samples of each aliquot were plaque titrated on 
EBK in 24-well cluster plates (Costar, Cambridge, MA) to confirm virus 
inactivation or absence of live virus in uninfected cultures. The 
infected-untreated (IU) aliquots contained 107 to 109 plaque forming units 
(PFU)/ml. 
Antigen Preparation 
The procedure followed was similar to that of Vestergaard (1973). 
Harvests were centrifuged for 4.5 hours at 36,000 X g. The pellets were 
resuspended in 3 to 4 volumes of either of two buffer solutions; 
glycine-Tris buffer, pH 9.0 (as utilized by Vestergaard and Bog-Hansen, 
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1975) containing 1% octylphenoxy polyethoxyethanol (Triton X-100, Sigma 
Chemical Company, and Fisher Scientific, Fairlawn, NJ), or Tris-Tricine 
buffer, pH 8.6 (buffer IV, Monthony, BioRad Laboratories, Richmond, CA}, 
containing 1% (immunoelectrophoresis buffer, !EB) or 5% Triton X-100. 
These suspensions then were sonicated for four 15-second periods on ice 
with a Branson Sonifier, Model 3600, with microtip at a setting of 6. This 
was followed by 16 to 32 hours of agitation on a circular shaker at 100 to 
250 rpm. The suspensions were centrifuged at 100, 000 X g for 1 to 2 hours, 
and the supernatant fluids, comprising the antigen preparations, were 
harvested and stored at 4°C. 
Four separate sets of antigen preparations were made and designated I, 
II, III, and IV. Set I was made with low cell passage virus, reconstituted 
from the pellet with glycine-Tris buffer, and consisted of an IU prepara-
tion only, which was used in 2DIE and PRSNIT tests. Set II also was made 
with low cell passage virus, reconstituted with glycine-Tris buffer, and 
consisted of IU, SI, and three treated preparations (formalin, heat, and 
UV}, which were used in 2DIE, FRIE, and PRSNIT tests. Set III was made 
with low cell passage virus, reconstituted with Tris-Tricine buffer, 5% 
Triton X-100, and consisted of IU, SI, and three treated preparations (BPL, 
formalin, and heat}, which were used in 2DIE, FRIE, and PRSNIT tests. Set 
IV was made with high cell passage virus and reconstituted with IEB. It 
consisted of IU and SI preparations, which were used as references in FRIE 
tests because of the similarity of IU-IV and IU-II patterns. 
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Antiserum Production and Globulin Preparation 
The BHV 1 antiserum was produced by hyperimmunization of four cattle 
through intranasal exposure and intramuscular injection of low passage live 
BHV 1 (Cooper strain) without adjuvant. Serum obtained at intervals during 
the immunization schedule was fractionated by a modification of the 
anion-exchange chromatographic procedure of Stanworth (1960) using 
DEAE-Sephadex A-50 (Pharmacia Fine Chemicals, Piscataway, NJ). The 
globulin preparations were concentrated to 25% of the original serum volume 
by pervaporation, filtered through a 0.45 micron filter, and pooled. A 
similar globulin preparation was made from anti -BHV 1 negative b'ovi ne fetal 
serum. Two antisera specific for a limited number of BHV 1 antigens were 
produced in calves by intramuscular injection with adjuvanted 2DIE gel 
secti ans c·antai ni ng specific anti gen-anti body arcs (unpublished 
observations, D. E. Reed, Veterinary Medical Research Institute, Iowa State 
University). Globulin preparations were produced from these antisera by 
ammonium sulfate precipitation. One serum, "VN- 11 , was specific for one 
antigen in this system, and lacked VN activity. The other serum, "VN+", 
was specific for four other antigens and had a VN titer of 64. 
2DIE Procedure 
The procedure followed was similar to that of Vestergaard (1973). 
Agarose gel was prepared from commercial immunoelectrophoresis tablets 
(BioRad Laboratories) by heating in water containing 1% Triton X-100. 
First dimension electrophoresis was performed on glass slides using IEB. 
Gel sections then were transferred to agarose support films (LKB 
Instruments, Rockville, MD) and 1% agarose gel, 48°C, containing 35% 
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anti-BHV 1 globulin, was pipetted onto the remaining area of the film. 
Following second dimension immunoelectroph6resis, films were stained with 
0.2% Coomassie Brilliant Blue R-250 (BioRad Laboratories). 
A modification of the 2DIE procedure described by Axelson and Bock 
(1972} was also used. The 2DIE with antigen addition (Ag-add} was 
performed by placing the preparation to be tested in a well centered below 
the well containing IU preparation prior to first dimension 
electrophoresis. 
FRIE Procedure 
Gels were cast on glass slides, cut, and transferred to agarose support 
films. Globulin-containing gel then was pipetted onto the remainder of the 
film, and wells were cut below the globulin-containing gel. Antigen 
preparations were pipetted into the wells, and immunoelectrophoresis was 
performed 1 to 3 hours later. 
Evaluation of 2DIE and FRIE Results 
Only arcs that were consistently reproduced and did not appear to be 
diffusion artifacts of other arcs (see Figure 1-B, antigens 5, 10, and 11} 
were used for analysis. Some unusual arcs were observed, complicating the 
evaluation. Examples of this are the connecting cathodal and anodal arcs 
of antigen 3.· The anodal arc of antigen 3 and the anodal side of the arc 
of antigen 4 of Set I were used for evaluation. In some cases, a heavy arc 
was seen which was determined to represent two antigens, and was evaluated 
as such. In other cases, arcs were seen that could represent either or 
both of two antigens, and so were not used in evaluation. Correlation of 
Figure 1. 2DIE patterns of reactions between infected~untreated or sham antigen preparations and BHVl 
antiserum or bovine fetal serum globulin preparations A - Infected-untreated preparation 
(II) with anti-BHV 1, B - infected-untreated preparation (I) with anti-BHV 1, C - sham 
preparation (II) with anti-BHV 1, D - infected-untreated preparation (II) with bovine fetal 
serum. 
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FRIE and 2DIE results was accomplished by performing 2DIE with first 
dimension electrophoresis times varying from Oto 30 minutes. 
The viral antigens that survived were identified by increases in arc 
area when treated antigen preparations were added to IU 2DIE tests (Ag-
add). This antigenic enhancement, as evaluated by superimposition of test 
and control films, was assigned relative values, "+" representing up to 25% 
of the enhancement produced by IU preparations (Figure 2-A), "++" 
representing 25 to 50% (Figures 2-A and 2-B), and''+++" representing 
greater than 50% (Figures 2-C and 2-D). For FRIE tests, the relative areas 
of fused rocket arcs demonstrating the reaction of identity were used. 
Quantities of antigen were again assigned relative values of"+", "++", and 
"+++". However, due to loss of definition in rocket patterns with dilution 
of control preparations, a calibration for these symbols was not possible. 
PRSNIT Procedure 
A modification of the technique described by Appleyard et al. (1964) 
and Cohen et al. (1972) was used. Dilutions of the preparation to be 
tested were incubated with equal volumes of a 1/30 dilution of BHV 1 
antiserum for 1 hour at 37°C with agitation each 15 minutes. An equal 
volume of live BHV 1 suspension (Cooper strain) was then added, followed by 
another 1-hour incubation at 37°C with agitation each 15 minutes. 
Following removal of the medium, 2- to 3-day old confluent EBK cell 
cultures in 24 well cluster cultures were inoculated with 0.1 ml/well. 
These were incubated at 37°C for 1 hour with agitation each 15 minutes, 
followed by addition of 0.5 ml of 1% gum tragacanth (Fisher Scientific, 
Fairlawn, NJ) in Earle's MEM. After 48 hours of incubation at 37°C, the 
Figure 2. Enhancement of infected-untreated 2DIE arc areas by addition of homologous antigen (Ag-add 
2DIE) Top well; A-D - infected-untreated preparation (I). Bottom well; A-D -
infected-untreated preparation (I) diluted 1:4, 1:2, 3:4, and 1:1, respectively (see Figure 
1-B). 
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plates were stained with crystal violet-formalin solution, washed, dried, 
and the microplaques counted using a dissection microscope. 
The antiserum control consisted of equal volumes of diluent and 1/30 
antiserum, and the virus control consisted of equal volumes of diluent and 
1/30 bovine fetal serum. The virus suspension was standardized to yield 45 
to 60 plaques/well, and the dilution of antiserum selected to neutralize 
673 of the virus. For evaluation, the average virus control plaque count 
(e.g., 60, or 0% VN) was defined as 1003 inhibition of VN activity of the 
antiserum. The average antiserum control plaque count (e.g., 20, or 673 
VN) was defined as 03 inhibition of VN activity in the antiserum. The 
dilution of antigen preparation which yielded plaque counts halfway between 
these two points (e.g., 40, or 333 VN) would be responsible for inhibiting 
503 of the VN activity in the antiserum. This dilution, calculated by 
arc-sine regression, was defined as the 503 PRSNIT titer. The SI plaque 
counts were used to correct for toxicity of the preparations. 
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RESULTS 
Twelve antigen-antibody arcs were repeatedly produced in IU 2DIE tests 
(Figure 1-A). One of these arcs is apparently cell-associated, as it was 
observed using SI, Set II (Figures 1-A and 1-C). However, the remaining 
11 arcs were clearly virus-specific, as none of the arcs were due to 
precipitation by normal serum components (Figure 1-D). Other precipitation 
lines were observed infrequently, and were not used in this study. The IU 
2DIE patterns showed some variation in the number of arcs detected, but 
those detected were very similar in position (Figures 1-A, 1-B, and 3-A). 
When antigens corresponding to IU antigens were present in treated 
preparations, their presence in the Ag-add procedure resulted in an 
increase in area under the respective arc (Figure 2); this permitted the 
identification of reactive antigens following the various treatments. When 
BHV 1 globulin was used in 2DIE with the antigen preparations of Sets II 
and III, six arcs were observed with BPL-treated, five with 
formalin-treated, four with heat-treated, and three with UV-treated 
preparations (Figure 3). These same antigen preparations were added to IU 
2DIE tests (Figure 4), with enhancement of arc areas as described in Table 
1. 
A FRIE test of Set II preparations was performed using Set IV as a 
control (Figure 5). This test demonstrated the large amounts of many IU 
antigens present in formalin-treated preparations, the small amounts of 
many IU antigens in heat-treated preparations, and the fact that none of 
the antigens in the UV preparations were identical to IU antigens. 
Figure 3. 2DIE patterns of reactions between treated antigen preparations and BHV 1 antiserum 
globulin preparations A - BPL treated preparation (III), B - Formalin treated preparation 
(III), C - heat treated preparation (III), D - UV treated preparation (II) (see Figures 1-A 
and 1-B). 

Figure 4. Identification of infected-untreated preparation antigens in treated preparations by 
enhancement of infected-untreated 2DIE arc areas (Ag-add 2DIE) Top well; A-D -
infected-untreated preparation (I). Bottom well; A - BPL-treated preparation (III), B -
formalin-treated preparation (III), C - heat-treated preparation (III), D - UV-treated 
preparation (II) (See Figure 1-A). 

Figure 5. FRIE patterns of reactions between sham, infected-untreated, or infected-treated antigen 
preparations and BHV 1 antiserum globulin preparations A - sham preparation (II), B, C, E, 
G, -·infected-untreated preparation (IV). D - formalin treated preparation (II), F - heat 
treated preparation (II), H - UV treated preparation (II). 

Table 1. 50% Plaque reduction serum neutralization inhibition test (PRSNIT) titers and relative 
antigen reactivities in two-dimensional immunoelectrophoresis with antigen addition of 
BHV 1-infected cell suspensions following inactivation of virus by various procedures 
Treatment 
Sham-inoculated 
Infected-
untreated 
BPLb-treated 
Formalin-
treated 
Heat-treated 
uvd-treated 
PRSNIT 
Titer 
0 
4300 
1500 
2500 
600 
0 
% of titer 
(infected-
untreated) 
0 
100 
35 
58 
14 
0 
1 2 
BHV 1 Antigen Specificities 
3 4 5 6 7 8 9 10 11 
Nega Neg Neg Neg Neg Neg Neg Neg Neg Neg Neg 
+++ +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ 
+++ ++ Neg +++ +++ NAc +++ +++ +++ NA +++ 
+++ +++ + ++ ++ NA +++ +++ +++ +++ +++ 
NA +++ Neg + + NA + + + + + 
a Neg, +, ++, +++ = Antigen reactivities relative to infected-untreated preparation. 
bBPL = Beta-propiolactone. 
cNA = (Data) not available. 
duv = Ultraviolet radiation. 
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When treated antigen preparations were tested by FRIE with "VN+" (specific 
for IU antigens 2, 6, 7, and 8) two arcs were produced by BPL-treated, 
formalin-treated and heat-treated preparations, whereas only one arc was 
produced by the UV-treated preparation. 
"Averaged" reactivities of individual antigens, as determined by 2DIE 
and FRIE tests illustrated in Figures 4 and 5, and averaged PRSNIT titers 
for the antigen preparations of Sets I, II, and III are presented in Table 
1. The lability of antigen 3 and the relative stability of antigen 2 are 
eviderit in this table. The marked reduction in antigenicity resulting from 
UV- or heat-treatment is also notable. 
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DISCUSSION 
Much of the work on inactivation of viruses has focused on the effect 
of treatment on the properties of intact virions, including infectivity 
(Griffin et al., 1958), absorption (Lancz, 1980), enzyme induction (Eglin 
et al., 1980), antigen induction (Ross et al., 1971), and immunogenicity 
(Matsuoka et al., 1972, Hristov and Karadjov, 1975, Schipper and Kelling, 
1975, Cappel, 1976), without examining the effects on individual antigens. 
However, much of the work on individual proteins or antigens has focused on 
enumeration and characterization of these structures in virion or infected 
cell preparations (Vestergaard, 1973, Heine et al., 1974, Misra et al., 
1981, Platt, 1982, Bolton et al., 1983), rarely examining their lability to 
common inactivation procedures or their roles except in regard to 
protection. The interface of these two emphases is important for the in 
vitro evaluation of inactivated vaccines, and for the differentiation of 
animals vaccinated with these products from those naturally exposed to the 
agent. 
This study examined the effects of common inactivation procedures on 
individual antigens (as measured by 2DIE and FRIE) and antigen reactivity 
(as measured by the PRSNIT test) to identify similar.ities and differences 
between treat~ents and to identify any antigens selectively diminished by 
all treatments. Antigenic analysis following solubilization with one agent 
is clearly not exhaustive. Some antigens may have been destroyed and 
others not exposed by the solubilization procedure. 
This information may be used to select the method of inactivation for 
the use of the viral preparation. The BPL and formalin treatments are 
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practical commercial techniques and formalin-inactivated vaccine is 
marketed in the United States. Most antigens were largely retained by 
either treatment. The PRSNIT titers were reduced, but retained significant 
activity compared to the control (averaging 30 to 60% activity). Of the 
treatments studied, BPL and formalin treatments are the most desirable for 
antigen survival and retention of immunogenicity. Heat treatment is a 
commonly used method for inactivation of viruses for experimentation, but 
this treatment markedly diminished PRSNIT titers (averaging 10 to 20% of 
control values). Heat treatment was relatively nonselective in its 
extensive diminution of BHV 1 antigens, sparing one. 
The marked damage by UV was observed consistently and is probably due 
to the high dosages required for complete inactivation in this study. 
These extreme dosages may have been necessitated by the turbidity and high 
virus concentration of the suspensions treated. The turbidity of the 
suspensions, which were concentrated solutions of infected cell scrapings, 
reduced the penetration of the UV radiation. The high virus concentration 
in the suspensions resulted in the equivalent of high multiplicity of 
infection in tests for inactivation. The survival of UV-irradiated HHV 1 
was reported to be increased at higher multiplicities of infection (Hall et 
al., 1980). This survival apparently was due to genetic exchanges between 
damaged HHV l'genomes, allowing production of undamaged virus. Thus, 
higher doses of radiation may have been required for complete inactivation 
of these suspensions than would have been necessary for suspensions of 
lower turbidity or virus concentration. 
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The difficulties of inactivation and the resulting requirement of high 
doses (which in turn may have caused secondary chemical changes in the 
environment of the virions) may mean most virion proteins had undergone 
degradation before all the virions had been inactivated. This degradation 
may mean that the four antigens in the UV-treated preparation which did not 
cross-react with IU antigens are internal antigens of the complex IU 
antigens. Although not exposed by Triton X-100 treatment, these antigens 
would be exposed by.:!!!_ vivo antigen processing, so hyperimmune serum should 
be expected to contain antibodies against them, as was demonstrated. 
Treatment with UV radiation therefore eliminated IU antigens, while 
retaining other precipitating viral antigens. 
The differences in stability between antigens relative to antigenicity 
as measured by PRSNIT titers may be important for the evaluation of multi-
component vaccines containing inactivated BHV 1. Quantitation of a labile 
antigen (e.g., Antigen 3) in comparison to a stable antigen (e.g., Antigen 
7) could provide a measure of inactivation of the BHV 1 fraction even in 
the presence of other fractions, which might prevent direct assays for live 
virus. The assay for the stable antigen could at the same time provide a 
measure of the BHV 1 antigenic mass of the product. 
The results of this study also indicate that serologic testing relative 
to selected antigens might differentiate uninfected BHV 1 vaccinates from 
naturally-infected animals. If Antigen 3 is reduced and altered by virus 
inactivation procedures to the point that it is no longer immunogenic, then 
antibodies to this antigen would not be expected in the serum of 
vaccinates. In contrast, animals exposed naturally to infectious BHV 1 
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would be expected to have antibodies to this antigen in their serum. This 
potential differentiation assumes that inactivated vaccines are used, that 
the reduction of reactivity of Antigen 3 as measured by..!..!!. vitro testing is 
a reflection of..!..!!. vivo reactivity, and that naturally-exposed animals 
possess detectable antibodies to Antigen 3. It also assumes that Antigen 3 
does not possess significant cross-reactivity with other infectious agents. 
The most likely agents to contain an antigen cross-reacting with Antigen 3 
of BHV 1 are other bovine herpesviruses. In a study of three other herpes-
viruses of cattle, BHV 2, BHV 3, and SHV 1, only SHV 1 contained an antigen 
cross-reacting with Antigen 3 (Part II, Levings et al., 1984b). This 
should not interfere with diagnosis of natural exposure to BHV 1, because 
with rare exceptions, SHV 1 infection is fatal in cattle (Hagemoser et al., 
1978, Toma and Gilet, 1978, Biront et al., 1982). Testing for antibodies 
specific for Antigen 3 should therefore allow concurrent vaccination and 
eradication efforts, making eradication of the diseases caused by BHV 1 
much less costly and more practical. 
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PART II. CROSS-REACTIONS OF BOVINE HERPESVIRUS 1 ANTIGENS WITH 
THOSE OF OTHER CATTLE HERPESVIRUSES 
This manuscript has been submitted to Veterinary Microbiology. 
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ABSTRACT 
Bovine embryonic kidney cells were infected with bovine herpesviruses 
(BHV 1, 2, or 3), suid herpesvirus 1 (SHV 1), or were sham-inoculated. 
When cytopathic effect was apparent, the cells were solubilized using 
Triton X-100 detergent. Resulting antigen preparations were tested by 
two-dimensional immunoelectrophoresis using bovine fetal serum and antisera 
directed against BHV 1, BHV 2, BHV 3, SHV 1, or a restricted spectrum of 
BHV 1 antigens. 
Interaction of BHV 1 antiserum with BHV 1 antigen preparations resulted 
in 11 precipitation arcs. The same antiserum produced three arcs with 
BHV 2, none with BHV 3, and five with SHV 1. The interaction of BHV 1 
antigen preparations with BHV 2, BHV 3, or SHV 1 antisera failed to produce 
demonstrable arcs. However, when heterologous antigen or antibody 
preparations were added to BHV 1 homologous two-dimensional 
immunoelectrophoresis tests, all 11 BHV 1 arcs were modified by BHV 1, two 
by BHV 2, four by BHV 3, and four by SHV 1 preparations. Two antigens were 
common to the four herpesviruses. 
·Antigen preparations were evaluated for their ability to inhibit virus 
neutralization by BHV 1 antiserum; only the BHV 1 preparation was active. 
Sera were tested for BHV 1 neutralizing activity; only BHV 1 antiserum and 
a serum specific for a restricted spectrum of BHV 1 antigens were active. 
A glycoprotein antigen associated with BHV 1 neutralization was identified; 
this antigen may be important in protection of animals against disease. 
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INTRODUCTION 
A variety of herpesviruses infects cattle, including infectious bovine 
rhinotracheitis virus (bovine herpesvirus 1, BHV 1), bovine mammillitis 
virus (bovine herpesvirus 2, BHV 2), Movar virus (bovine herpesvirus 3, 
BHV 3), pseudorabies virus (suid herpesvirus 1, SHV 1), and malignant 
catarrhal fever virus. The nomenclature applied to these viruses has been 
inconsistent; the system proposed by Roizman et al. (1981) is used here. 
The immunologic relationships between these herpesviruses have been 
studied by a variety of experimental approaches. However, the relation-
ships of bovine herpesviruses remain poorly defined (Killington et al., 
1977), and it has been observed that "the number and kinds of shared 
components by any given herpesvirus depends on the methods of antigen 
preparation and the sensitivities of the tests for each particular system" 
(Evans et al., 1972). 
The antigenic relationship of BHV 1 to other BHVs is subject to inter-
pretation. Sterz et al. (1974) were unable to demonstrate cross-reactions 
between BHV 1 and BHV 2 by immunodiffusion (ID), immunofluorescence (IF), 
complement fixation (CF), or virus neutralization (VN) tests. Potgieter 
and Mare (1974b) were unable to demonstrate cross-reaction between BHV 1 
and BHV 3 by IF or VN. Although BHV 1 and SHV 1 did not cross-neutralize 
when rabbit sera were used (Plummer, 1964), 33% of 90 cattle sera 
possessing neutralizing antibodies for BHV 1 as a result of infection or 
vaccination also possessed antibodies which neutralized SHV 1 
(Aguilar-Setien et al., 1979c). The cattle sera had BHV 1 neutralizing 
antibody titers of 8 or greater. However, only 4% of 89 swine sera 
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possessing neutralizing antibodies for SHV 1 also possessed antibodies 
which neutralized BHV 1. Cattle sensitized to BHV 1 responded to injection 
of inactivated BHV 1 and SHV 1 with similar delayed hypersensitivity 
reactions (Aguilar-Setien et al., 1979a). Vaccination with 
temperature-sensitive mutants of BHV 1 did not protect cattle from SHV 1 
challenge, but neither did vaccination with avirulent or killed SHV 1 
(Biront et al., 1982). Wellemans et al. (1980) observed that SHV 1 
antibodies do not react in an indirect IF (IIF) test for BHV 1 antibodies. 
However, BHV 1 and SHV 1 have been reported to share two antigens 
detectable by immunoelectrophoresis (IE) (Evans et al., 1973). 
Smith (1976) reported work by Bartha indicating that BHV 2 is not 
serologically related to BHV 3. Although BHV 2 does not cross-react with 
SHV 1 by IF, CF, or VN (Sterz et al., 1974), ID studies revealed an antigen 
common to BHV 2, SHV 1, and two other herpesviruses (Killington et al., 
1977). This polypeptide antigen was identified by polyacrylamide gel 
electrophoresis (PAGE) of antigens precipitated by heterologous antisera 
(Yeo et al., 1981), and shown to be a major DNA-binding protein for each 
virus (Littler et al., 1981), with a highly conserved amino acid sequence. 
Elucidation of relationships between herpesviruses of cattle has 
application beyond the delineation of taxa. Identification of unique 
antigens in each bovine herpesvirus would aid specific diagnosis, e. g. by 
the production and use of monospecific antisera or monoclonal antibodies. 
Identification of antigens cross-reacting between bovine herpesviruses, 
especially those common to all these viruses, would be of value in 
detection of extraneous herpesviruses in bovine biologics and in group-
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specific diagnosis. The role of shared antigens in infection and immunity, 
including cross-protection, is of theoretical and practical (vaccination) 
importance. 
The serological relationships of BHV 1 to three other herpesviruses 
that infect cattle were examined in this study by the use of 
two-dimensional immunoelectrophoresis (2DIE), plaque reduction serum 
neutralization (PRSN), and plaque reduction serum neutralization inhibition 
tests (PRSNIT). Cell cultures infected with each of the viruses were 
solubilized using a nonionic detergent, and tested against globulin 
preparations derived from homologous and heterologous antisera. 
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MATERIALS AND METHODS 
Vi ruses 
The bovine herpesviruses and their sources were as follows: BHV 1 
(Cooper strain, NVSL), BHV 2 (New York-1 strain, NVSL), BHV 3 (3373 strain, 
D. E. Reed), and SHV 1 (S62-26 strain, NVSL). All viruses were type 
viruses of limited cell passage. 
Antigen Preparation 
The procedure followed has been described previously (Part I, Levings 
et al., 1984a). Briefly, cell cultures (embryonic bovine kidney, EBK) were 
grown to confluency in roller bottles (Corning Glass Works, Corning, NY) 
using Eagle's minimum essential medium (EMEM, Grand Island Biological 
Company, Grand Island, NY) containing 10% bovine fetal serum. These 
cultures were infected with BHV 1 at a multiplicity of infection (MOI) of 
0.5 to 3.0, BHV 2 at MDI 0.02 to 0.1, BHV 3 at MDI 0.0002 to 0.01, or SHV 1 
at MDI 0.5 to 3.0 in EMEM without serum. Sham-inoculated (SI) cultures 
were inoculated with EMEM only. When the cytopathic effect reached 50 to 
90%, the cultures were harvested and centrifuged for 4.5 hours at 36,000 X 
g. The pellets were resuspended in glycine-Tris {Sigma Chemical Company, 
St. Louis, MO) buffer (pH 9.0) containing 1.0% Triton X-100 (Sigma Chemical 
Company, and Fisher Scientific, Fairlawn, NJ) or Tris-Tricine (BioRad 
Laboratories, Richmond, CA) buffer (pH 8.6) containing 1.0% Triton X-100 
(immunoelectrophoresis buffer, IEB). Following sonication and agitation, 
the suspensions were centrifuged for 1 to 2 hours at 100,000 X g and the 
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supernatant fluids, comprising the antigen preparations, were harvested and 
stored at 4°C. 
Four separate sets of antigen preparations were made and designated I, 
II, III, and IV. Set I was made using glycine-Tris buffer and consisted of 
a BHV 1-infected preparation only. Set II was made using glycine-Tris 
buffer and consisted of BHV 1-infected and SI preparations. Sets III and 
IV were made using IEB and consisted of SI and BHV 1-, BHV 2-, BHV 3-, and 
SHV 1-infected preparations. 
BHV 1 antigen preparations were subjected to affinity chromatography 
using Sepharose-linked Ricines communes agglutinin (RCA, E-Y Laboratories, 
San Mateo, CA), a lectin specific for beta-linked D-galactose and 
structurally similar residues. Following a 16-hour incubation at 4°C, 
unbound materials were washed from the column with four volumes of !EB. 
One hour later, bound antigen was eluted with three volumes of IEB 
containing 0.2 M galactose. This glycoprotein preparation was concentrated 
to the original preparation volume by pervaporation and dialyzed against 
!EB. 
Antiserum Production 
BHV 1 antiserum production and pooling has been previously described 
(Part I, LeviDgs et al., 1984a). Briefly, two calves were injected 
intramuscularly (IM) with live virus at intervals and bled five times. The 
harvested sera had BHV 1 VN titers greater than 32 and SHV 1 VN titers 
greater than 8. Two other calves were exposed, once intranasally and twice 
IM, and were bled once. The harvested pooled serum had a BHV 1 VN titer 
greater than 256 and a negligible SHV 1 VN titer. All calves were BHV 1 
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and SHV 1 seronegative prior to immunization. The sera, negative by VN for 
BHV 2 and negative by IIF for BHV 3, were pooled for use in this study. 
BHV 2 antiserum was provided by M. L. Snyder (NVSL). One calf was 
injected IM at intervals and ultimately intravenously (IV) with BHV 2. The 
serum had an anti-BHV 2 titer of 90 by VN and 20,480 by !IF. This serum 
was negative by these tests for BHV 1 and SHV 1 and was negative by IIF for 
BHV 3. 
BHV 3 antiserum was provided by F. A. Osorio (Iowa State University). 
One calf was injected IV with BHV 3, 3374 strain (Osorio and Reed, 1983). 
A persistent infection ensued during which virus was repeatedly isolated 
from peripheral blood leukocyte cultures. Harvested serum had an anti-BHV 
3 titer of 160 by IIF, and a negligible titer by VN. This serum was 
negative by these tests for BHV 1, and was negative for SHV 1 by VN. This 
calf was seropositive by !IF for BHV 2 pre- and post-injection. 
SHV 1 antiserum was provided by P. D. Beard (NVSL). One calf was 
injected IM twice with a Triton X-100 solubilized antigen preparation of 
SHV 1, incorporated in incomplete Freund's adjuvant (Grand Island 
Biological Company). Harvested serum had an SHV 1 VN titer of 13, was 
negative by VN for BHV 1 and BHV 2, and was negative by !IF for BHV 3. 
\ 
These sera were fractionated by a modification of the anion-exchange 
chromatography method of Stanworth (1960), using DEAE-Sephadex A-50 
(Pharmacia Fine Chemicals, Piscataway, NY). The globulin preparations were 
concentrated by pervaporation to 25% of the original serum volume and 
filtered through a 0.45 micron filter. A similar globulin preparation was 
made from bovine fetal serum. 
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Two antisera specific for a limited number of BHV 1 antigens were 
produced in calves by intramuscular injection with adjuvanted 2DIE gel 
sections containing specific antigen-antibody arcs (unpublished 
observations, D. E. Reed, Veterinary Medical Research Institute, Iowa State 
University). Globulin preparations were produced from these antisera by 
ammonium sulfate precipitation. One serum, "VN- 11 , was specific for one 
antigen in this system, and lacked VN activity. The other serum, "VN+", 
was specific for four other antigens and had a VN titer of 64. 
2DIE Procedure 
The procedure followed was similar to that of Vestergaard (1973). 
Agarose gel was prepared from commercial immunoelectrophoresis tablets 
(BioRad Laboratories) by heating in water containing 1.0% Triton X-100. 
First dimension electrophoresis was performed on glass slides using IEB. 
Gel sections were then transferred to agarose support films (LKB 
Instruments, Rockville, MD) and 1% agarose gel, 48°C, containing globulin, 
was pipetted onto the remaining area of the film. Following second 
dimension immunoelectrophosesis, films were stained with 0.2% Coomassie 
Brilliant Blue R-250 (BioRad Laboratories). 
Modifications of 2DIE procedure described by Axelson and Bock (1972) 
were also used. The 2DIE with antigen addition, (Ag-add), was performed by 
placing the preparation to be tested in a well centered below the well 
containing BHV 1 preparation prior to first dimension electrophoresis. The 
2DIE with antibody addition, (Ab-add), was performed by incorporating the 
globulin preparation to be tested into 1% agarose gel containing BHV 1 
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globulin and pipetted onto the film prior to second dimension immuno-
el ectrophoresi s. 
Evaluation of 2DIE Results 
Only arcs that were consistently reproduced and did not appear to be 
diffusion artifacts of other arcs (see Figure 1-B, antigens 5, 10, and 11) 
were used for analysis. Some unusual arcs were observed complicating the 
evaluation. Examples of this are the connecting cathodal and anodal arcs 
of Antigen 3. The anodal arc of Antigen 3 and the anodal side of the arc 
of Antigen 4 of set I were used for evaluation. In some cases, a heavy arc 
was seen which was determined to represent two antigens and was evaluated 
as such. In other cases, arcs were seen that could represent either or 
both of two antigens, and were not used in evaluation. 
Common viral antigens were identified by increases in arc area when 
heterologous antigen preparations were added to homologous BHV 1 2DIE tests 
(Ag-add). This antigenic enhancement, evaluated by superimposition of test 
and control films, was assigned relative values, "+'' representing up to 25% 
of the enhancement produced by BHV 1 antigen preparations {Figure 2-A), 
"++" representing 25 to 50% (Figures 2-A and 2-B), and "+++" representing 
greater than 50% (Figures 2-C and 2-D). 
Common antibodies in the antisera studied were identified by the 
decrease in arc area observed when heterologous globulin preparations were 
added to homologous BHV 1 2DIE tests (Ab-add). This antibody-mediated 
depression was assigned relative values of "+'', ''++'', and "+++", repre-
senting the percentage of effect BHV 1 globulin had on arcs. 
Figure 1. 2DIE patterns of reactions between BHV 1-infected or sham antigen preparations and BHV 1 
antiserum or bovine fetal serum globulin preparations A - BHV 1-infected preparation (·II) 
with anti-BHV 1, B - BHV 1-infected preparation (I) with anti-BHV 1, C - sham preparation 
(II) wi~h anti-BHV 1, D - BHV 1-infected preparation (II) with bovine fetal serum. 

Figure 2. Enhancement of BHV 1 homologous 2DIE arc areas by addition of homologous antigen (Ag-add 
2DIE) Top well: A-D - BHV 1-infected preparation (I). Bottom well: A-D - BHV 1-infected 
preparation (I) diluted 1:4, 1:2, 3:4, and 1:1 respectively (See Figure 1-B). 
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PRSN Procedure 
Dilutions of antisera to be tested were incubated with equal volumes of 
a fixed dilution of BHV 1 (Cooper strain) for 1 hour at 37°C with agitation 
every 15 minutes. Following removal of the medium, 2- to 3-day-old 
confluent EBK cell cultures in 24 well cluster cultures (Costar, Cambridge, 
MA) were inoculated with 0.1 ml/well. These were incubated at 37°C for 1 
hour with agitation every 15 minutes, followed by addition of 0.5 ml of 1% 
gum tragacanth (Fisher Scientific, Fairlawn, NJ) in EMEM. After 48 hours 
incubation at 37°C, the plates were stained with crystal violet-formalin 
solution, washed, dried, and the microplaques counted using a dissection 
microscope. Virus control consisted of equivalent dilutions of bovine 
fetal serum and virus. The dilution used in the virus suspension was 
standardized to yield 45 to 60 plaques/well. Fifty percent neutralization 
was calculated by arc sine regression. 
PRSNIT Procedure 
A modification of the technique described by Appleyard et al. (1964) 
and Cohen et al. (1972) was used. Dilutions of the preparation to be 
tested were incubated with equal volumes of a 1:30 dilution of BHV 1 
antiserum for 1 hour at 37°C with agitation each 15 minutes. An equal 
·volume of live BHV 1 suspension (Cooper strain) was then added, followed by 
another 1 hour incubation at 3'l°C with agitation each 15 minutes. 
Inoculation, incubation, staining, etc., was performed as described in 
"PRSN procedure". 
The antiserum control consisted of equal volumes of diluent and 1:30 
antiserum, and the virus control consisted of equal volumes of diluent and 
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1:30 bovine fetal serum. The virus suspension was standardized to yield 45 
to 60 plaques/well, and the dilution of antiserum selected to neutralize 
67% of the virus. For evaluation, the average virus control plaque count 
(e.g., 60, or 0% VN) was defined as 100% inhibition of VN activity of the 
antiserum. The average antiserum control plaque count (e.g., 20, or 67% 
VN) was defined as 0% inhibition of VN activity in the antiserum. The 
dilution of antigen preparation which yielded plaque counts halfway between 
these two points (e.g., 40, or 33% VN) would be responsible for inhibiting 
50% of the VN activity in the antiserum. This dilution, calculated by 
arc-sine regression, was defined as the 50% PRSNIT titer. The SI plaque 
counts were used to correct for toxicity of the preparations. 
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RESULTS 
Twelve antigen-antibody arcs were repeatedly produced in homologous 
BHV 1 2DIE tests (Figure 1-A). One of these arcs is apparently 
cell-associated, as it was observed using SI set II (Figures 1-A and 1-C). 
However, the remaining 11 arcs were clearly virus specific, as none of the 
arcs were due to precipitation by normal serum components (Figure 1-D). 
Other precipitation lines were observed infrequently and were not used in 
this study. The BHV 1 homologous 2DIE patterns showed some variation in 
the numbers of arcs detected, but those detected were very similar in 
position {Figures 1-A, 1-B, and 3-A). 
When BHV 1 globulin was used in 2DIE with the antigen preparations of 
sets III and IV, 10 arcs were produced by BHV 1, three by BHV 2, none by 
BHV 3, and five by SHV 1 (Figure 3). These same antigen preparations were 
added to BHV 1 homologous 2DIE tests and enhanced arc areas as follows: 
BHV 1, Antigens 1 to 11; BHV 2, Antigen 1; BHV 3, Antigens 1 and 2; and 
SHV 1, Antigens 1, 3, 6, and 8 (Figure 4 and Table 1). 
When heterologous globulin preparations were used in 2DIE with BHV 1 
antigen preparations, no arcs were produced. These same globulin 
preparations were added to BHV 1 homologous 2DIE tests and decreased arc 
areas as follows: BHV 1 globulin, Antigens 1 to 11; BHV 2 globulin, 
Antigens 1 and 8; BHV 3 globulin, Antigens 1, 6, and 8; and SHV 1 globulin, 
none of the antigens {Figure 5 and Table l)~ 
Antisera produced against 2DIE gel sections containing antigen-antibody 
arcs had very limited specificity as determined by 2DIE (Figure 6). The 
Figure 3. 2DIE patterns of reactions between herpesvirus-infected antigen preparations (III) and 
BHV 1 antiserum globulin preparations A - BHV 1, B - SHV 1, C - BHV 2, D - BHV 3 (See 
Figures 1-A and 1-B). 

Figure 4. Identification of BHV I-infected preparation antigens in herpesvirus-infected antigen 
preparat.ions (III) by enhancement of BHV I homologous 2DIE arc areas (Ag-add 2DIE) 
Top well: A-D - BHV I-infected preparation (II). Bottom well: A - BHV I, B - SHV I, C -
BHV 2, D - BHV 3 (See Figure I-A). 

Figure 5. Identification of BHV 1 antibodies in herpesvirus antisera globulin preparations by 
depression of BHV 1 homologous 2DIE arc areas {Ab-add 2DIE) A - BHV 1 antiserum; B - SHV 1 
antiserum; C - BHV 2 antiserum; D - BHV 3 antiserum (see Figures 1-A and 1-B). 

Figure 6. Detection and identification of BHV 1 antibodies in "VN+" and "VN-" by 2DIE with 
BHV 1-infected preparation (II) and by depression of BHV 1 homologous 2DIE arc areas 
(Ab-add 2DIE) A - "VN-'', B - "VN+", C - "VN-'', D - "VN+" (See Figure 1-A). 
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Table 1. Distribution and relative reactivity in two-dimensional 
immunoelectrophoresis with antigen or antibody addition of BHV 1 
antigen specificities associated.with various herpesviruses 
Antigen or Antibody Association with BHVla 
Preparation Added 
BHV 2b +C Neg. Neg. 
Anti -BHV 2 ++ Neg. Neg. 
BHV 3d + + Neg. 
Anti -BHV 3 ++ Neg. Neg. 
SHV le ++ Neg. + 
Anti-SHV 1 Neg. Neg. Neg. 
aBHV 1 = Infectious bovine rhinotracheitis virus. 
bBHV 2 =Bovine mammillitis virus. 
Specificities 
6 
Neg. 
Neg. 
Neg. 
+ 
+ 
Neg. 
c+,++ =Antigen reactivities relative to BHV 1 preparations. 
dBHV 3 = Movar virus. 
eSHV 1 = Pseudorabies virus. 
8 
Neg. 
++ 
Neg. 
++ 
++ 
Neg. 
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"VN-" serum was specific for antigen 10 by antibody-addition 2DIE. The 
"VN+" serum was specific for Antigens 2, 6; 7, and 8 by the same technique. 
Antigen preparations of each of the four herpesviruses studied were 
evaluated for ability to inhibit PRSN of BHV 1; only the BHV 1 preparation 
was positive. Sera were tested for PRSN of BHV 1; only anti-BHV 1 and 
"VN+" were postiti ve. 
The BHV 1 Antigens 7, 8, and 11 were identified as glycoproteins by 
antigen-addition 2DIE using RCA-fractionated preparations. 
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DISCUSSION 
The serological cross-reactions between BHV 1 and three other herpes-
viruses that infect cattle were examined to identify antigens common to two 
or more of these viruses. The experimental procedure, antigenic analysis 
by 2DIE of virus-infected cell preparations solubilized by Triton X-100, 
was se 1 ected because: ( 1) Tri ton X-100 treatment was reported by 
Vestergaard et al. (1977) to free 90% of the protein of cells infected with 
human herpesvirus 1 (HHV 1); (2) when controlled as in this study, only 
virus-determined antigen specificities should have been detected; (3)· use 
of hyperimmune anti-BHV 1 globulin together with modification of the 2DIE 
with Ag-add and Ab-add techniques should have detected most BHV 1 precipi-
tating and nonprecipitating antigen-antibody reactions (Axelson and Bock, 
1972). Although the procedure only measured antigens resulting from 
solubilization of virus-infected cells, and did not define those components 
on the basis of size or complexity, the system did have the potential for 
relating antigenic composition of the viruses by serologic reactivity. 
This study delineated certain antigenic relationships between the 
viruses including the demonstration of certain virus-restricted (unique) 
and shared (cross-reacting) antigens. Cross-reacting antigens may have 
value in construction of "serons," defined by Honess and Watson (1977) as 
"a cluster of viruses defined by significant serological relationships." 
This study has demonstrated five BHV 1 antigens common to other cattle 
herpesviruses. Two of the antigens were common to the four viruses. The 
shared antigens may correspond to structures or functions common to herpes-
vi ruses in general, e.g., ·the DNA-binding protein described by Killington 
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et al. (1977), or they may represent a cattle herpesvirus-common structure, 
e.g., a protein necessary for infection of bovine cells similar to that 
described by Sarmiento et al. (1979) for HHV 1 penetration. Identification 
of specific antigens common to all cattle herpesviruses, or even all 
herpesviruses, could allow development of a serological test to detect the 
extraneous viruses in bovine constitutions. This is a problem which cannot 
be addressed practically by testing individually for each possible 
contaminant. 
In addition to the two antigens common to the four viruses, one BHV 1 
antigen was shared with BHV 2, two were detected in BHV 3, and two were 
found in SHV 1. One BHV 1 antigen (6) was observed in BHV 3 and SHV 1, but 
not BHV 2. This variation in the number and identity of common structures 
may be related to molecular variation, e.g., the thymidine kinase variation 
observed in HHVs by Honess and Watson (1977). An alternative explanation 
is that some of these antigens are common to all the cattle herpesviruses, 
or all the herpesviruses, but because the antigens are present in limited 
concentration, they are not detected with some antigen or antibody 
preparati ans. 
The norm in this study was for antigen and antibody preparations to 
evidence greater activity when added to BHV 1 homologous 2DIE tests than 
was demonstrated when tested alone. These observations may be due to 
the superior sensitivity of the addition techniques. However, interesting 
exceptions were noted with BHV 2 and SHV 1 antigen preparations which 
produced more arcs with BHV 1 globulin than were affected by these 
preparations in BHV 1 homologous 2DIE tests. This result may be due to the 
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molecular characteristics of the cross-reacting antigens. The dissociated 
viral antigens are probably complexes of antigenic molecules, or molecules 
with multiple determinants, with heterogeneity among the herpesviruses 
studied. This would account for the differing expression of antigenic 
preparations in the test procedures. Thus, the three antigens of BHV 2 
which reacted with BHV 1 globulin may represent separate molecules, while 
those specificities may be distributed on only two BHV 1 molecules 
(Antigens 1 and 8, see Table 1). The SHV 1 component which did not 
influence a BHV 1 homologous 2DIE arc, but precipitated separately (Figure 
4-B), may be due to an SHV 1 antigen which shares only one of many 
determinants with a BHV 1 antigen, with an indetectable line of partial 
identity (Axelson and Bock, 1972). Alternatively, this SHV 1 arc may be 
due to an SHV 1 surface determinant which is hidden in a BHV 1 antigen 
complex because it was not exposed by the solubilization procedure. 
However, this antigen would be exposed by.:!..!!_ vivo antigen processing, so 
antibodies against it should be present in hyperimmune BHV 1 antiserum, as 
was shown (Figures 3-B and 4-B). This antigen is of particular interest, 
because this same mechanism (surface versus hidden) may explain why BHV 1 
antiserum is capable of neutralizing SHV 1, while SHV 1 antiserum has been 
reported not to neutralize BHV 1 (Aguilar-Setien et al., 1979c). 
The BHV l·unique antigens may be useful for species-specific diagnosis. 
Those BHV 1 antigens (4, 5, 7, 9, 10, and 11) that did not cross-react with 
other cattle herpesviruses in this study are not likely to cross-react with 
other, less closely related, viruses infecting cattle. If these antigens 
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are not found in other cattle herpesviruses, they could be used to refine 
BHV 1 diagnosis. 
The experimentation revealed that an association with BHV 1 
neutralization could be made for one antigen, while this association was 
ruled out for several others. A role for cross-reacting antigens in BHV 1 
neutralization was eliminated by the failure of the other cattle 
herpesviruses to inhibit neutralization of BHV 1 or induce antibodies 
capable of neutralizing BHVl. For this reason, Antigens 1, 2, 3, 6, and 8 
are probably not BHV 1 neutralization epitopes. The VN+ serum reacted with 
BHV 1 Antigens 2, 6, 7, and 8. Therefore, by elimination, Antigen 7 is 
associated with neutralization of BHV 1. Similarly, Antigen 10 probably is 
not associated with BHV 1 neutralization because VN- is specific for it. 
The association of Antigen 7 with neutralization of BHV 1 confirms and 
extends the observations of one of the authors (D. E. Reed), who 
demonstrated neutralizing activity in a serum directed against a limited 
mixture of BHV 1 antigens, including Antigen 7. Therefore, a subunit or 
genetically engineered vaccine containing this antigen may have potential 
for immunoprophylaxis. Such an antigen could be protective without the 
safety or latency problems that may be encountered using other herpesvirus 
vaccines containing DNA (Reed, 1980). Such a vaccine would allow con-
current vaccination and serological testing for naturally exposed animals 
by testing for antigens not included in the vaccine. This would make 
eradication of the diseases caused by BHV 1 much less costly and more 
practical. 
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GENERAL SUMMARY 
This study involved the identification of those bovine herpesvirus 1 
(BHV 1) antigens affected quantitatively by virus inactivation and those 
cross-reacting serologically with antigens of other cattle herpesviruses. 
Two-dimensional and fused rocket immunoelectrophoresis were used to detect 
11 viral antigens in detergent-solubilized BHV I-infected cells. 
The effects of four widely used methods of virus inactivation on BHV 1 
antigens were examined. Antigen preparations treated with beta-
propiolactone (BPL) or formalin retained a large measure of most of the 
individual antigens, as well as substantial total antigen reactivity. 
Antigen reactivity was measured by a plaque reduction serum neutralization 
inhibition test (PRSNIT). Heat treatment (56°C x 1 hr) was relatively 
nonselective in its extensive reduction of BHV 1 antigens, and PRSNIT 
activity of these treated preparations was low. Treatment with ultraviolet 
(UV) radiation eliminated all of the antigens studied, and PRSNIT activity 
of these preparations was not detectable. One BHV 1 antigen (3) was found 
to be labile to all treatments (negative or <25% of control levels). 
Another (2) was found to be relatively stable (>50% of control levels in 
BPL-, formalin-, and heat-treated preparations). 
The cross-reactions of the BHV 1 antigens with those of other cattle 
herpesviruses (BHV 2, BHV 3, and suid herpesvirus 1, SHV 1) were also 
investigated. Five BHV 1 antigens (1, 2, 3, 6, and 8) were found to cross-
react with the antigens of at least one of these other herpesviruses, Two 
of the BHV 1 antigen specificities (1 and 8) were common to all of the 
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viruses studied. One (6) was shared with two other cattle herpesviruses; 
two (2 and 3} were shared with one other virus. 
Variation in the effect of the inactivation treatments may be valuable 
for selection of inactivation methods as they relate to antigenicity of the 
final product, cost, ease of preparation, and toxicity. The antigen prep-
arations used in this study were very turbid and had high preinactivation 
titers. Therefore, excessive UV irradiation may have been necessary for 
complete inactivation, which may account for the destruction of all 11 
antigens studied. The.use of tissue culture assays for inactivation may 
have contributed to this necessity for excessive treatment, as repair of 
UV-inactivated virion infectivity is known to occur under conditions of 
high multiplicity of infection. 
A one-way neutralization of SHV 1 with BHV 1 antisera has been reported 
and was confirmed in this study. A SHV 1 antigen was detected which was 
precipitated by BHV 1 antiserum but did not coprecipitate with BHV 1 
antigens. This antigen may represent an internal or "hidden" BHV 1 deter-
minant (unavailable to antibody, neutralization not possible) which is a 
surface SHV 1 determinant (available to antibody, neutralization possible). 
Although hidden in whole (and gently solubilized} BHV 1 virus preparations, 
such a determinant would be exposed by.:!.!!_ vivo antigen processing. Thus, 
antibodies against it would be expected to occur in hyperimmune BHV 1 
antisera, which were used in this study to precipitate the antigen. A 
similar one-way neutralization of HHV 1 with BHV 2 antiserum has been 
reported {Pauli et al., 1979). Ludwig (1983} noted that a variety of 
evidence suggests the common antigen of HHV 1 and BHV 2 is an ''integral 
91 
part of the membrane" in HHV 1, but on the "internal side'' of the envelope 
of BHV 2. 
Those antigens found only in BHV 1 (BHV 1 unique) are important for the 
development of BHV 1-specific serodiagnostic tests. Six BHV 1 antigens 
were not observed to cross-react with the three other cattle herpesviruses 
used in this study. Serologic cross-reactions would be most likely in such 
closely related viruses, so cross-reactions with other cattle viruses are 
improbable. Should further experimentation fail to demonstrate cross-
reactions with another virus, these antigens could be considered BHV 1-
specific and used to refine BHV 1 diagnosis. 
Six BHV 1 antigens identified in this experimentation warrant special 
attention. Antigens 1 and 8 are common to all four cattle herpesviruses 
studied. The shared antigens may be responsible for structures or 
functions common to all herpesviruses or to all cattle herpesviruses. If 
either of these antigens could be shown by further experimentation to be 
common to all cattle herpesviruses or all herpesviruses, a test based on 
that antigen might .be used to detect extraneous viruses of that group in 
bov~ne biologics. Contamination of products with these viruses is more 
practically addressed by group-specific testing than by virus-specific 
testing. Antigen 6 cross-reacted with antigens of BHV 3 and SHV 1, but not 
BHV 2. This may be due to limited concentrations of reagents (allowing 
cross-reactions to go undetected) or degrees of variation of similar 
structures in bovine herpesviruses. BHV 1 Antigen 2 was shown to be stable 
to treatment with BPL, formalin and heat. As the only heat-stable antigen 
detected, it is enriched relative to the other BHV 1 antigens by heat 
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treatment of virus or antigen preparations. It is also an antigen of 
cross-reaction with BHV 3. In view of the.low titers in which BHV 3 is 
produced in tissue culture, a heat-treated BHV 1 preparation might have 
potential as a diagnostic reagent for BHV 3 screening, when used in 
conjunction with BHV 1 diagnosis. 
Of interest is the fact that only one BHV 1 antigen (3) was found to be 
labile to all inactivation techniques tested. Its unique lability to three 
divergent inactivation treatments (BPL, Formalin, and Heat) suggests a 
common site and perhaps a common mechanism for inactivation. It might 
·.further be suggested that (being the only antigen eliminated by heat) 
Antigen 3 is the site of temperature sensitive mutant modification. It 
might be supposed that BHV 1 Antigen 3 represents a vital structure or 
function in the infectivity of bovine herpesviruses, which could be 
expected to be highly conserved, but Antigen 3 is not a cattle herpesvirus-
common antigen as detected in this study. Because BHV 1 Antigen 3 was 
reduced in quantity by all treatments, it may be that the humoral immune 
response to Antigen 3 in those animals exposed to treated preparations is 
also reduced. Thus, an assay for antibody against Antigen 3 relative to 
those directed against another antigen might distinguish noninfected 
animals vaccinated with inactivated product from naturally-infected 
animals. This assumes antibodies against Antigen 3 would not be present 
from infection with another agent. Cattle herpesviruses would be the most 
likely agents to contain antigens cross-reacting with BHV 1 Antigen 3, but 
of those studied only SHV 1 (almost uniformly fatal in cattle) contains 
such an antigen. If other cross-reacting antigens are not found, a BHV 1-
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infection specific serodiagnostic test based on Antigen 3 might be 
practical. It would aid epidemiologic investigation, allow more widespread 
vaccination of animals destined for export, and make eradication of the 
diseases caused by BHV 1 possible with existing vaccines. 
Of those BHV 1 antigens reacting with a BHV !-neutralizing antiserum, 
Antigen 7 would appear to be of singular importance. BHV 1 Antigens 2, 6, 
7, and 8 reacted with a BHV !-neutralizing serum raised against an antigen-
antibody precipitate in agarose. Those BHV 1 antigens which cross-reacted 
with other cattle herpesviruses in this study are not likely to play a role 
in BHV 1 neutralization, because antisera directed against these viruses 
did not neutralize BHV 1, and antigen preparations of these viruses did not 
inhibit neutralization of BHV 1. Thus, Antigen 7 is singled out as an 
important BHV 1 neutralization epitope. The use of such an antigen in 
immunoprophylaxis might be protective without the safety and latency 
problems inherent in the use of current products. The use of a defined 
vaccine would al.so allow more certain differentiation between uninfected 
vaccinates and infected animals than that allowed by the present vaccines. 
This study identifies several areas of additional research that should 
be pursued. These include correlation of 2DIE and PAGE results, investi-
gation of cross-reactions between BHV 1 antigens and those of additional 
herpesviruses; and isolation and use of particular BHV 1 antigens. 
There is a need to correlate information obtained from two dimensional 
immunoelectrophoresis (2DIE) and polyacrylamide gel electrophoresis (PAGE) 
because of the unique information which may be attained from modifications 
of agarose immunoprecipitation and modifications of PAGE. Correlation may 
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be accomplished using radiolabeled specific antisera or monoclonal 
antibodies following electrophoretic protein transfer to nitrocellulose 
from each pattern. Antigens 1, 3, 7, 8, and that antigen which may be on 
the surface of SHV 1 but hidden in BHV 1 merit particular attention. The 
extension of this correlation to 2DIE and PAGE of SHV 1 and other herpes-
viruses would also be useful. 
The relationship of BHV 1 antigens to those of a broad spectrum of 
herpesviruses needs to be investigated. Cross-reactions with BHV 1 
antigens 1, 3, 7, and 8 could be especially meaningful. BHV 1 Antigens 1 
and 8 cross-reacted with each of the cattle herpesviruses examined in this 
study. Further investigation is required to characterize them as common to 
herpesviruses, bovine herpesviruses, or some other restricted group of 
herpesviruses. BHV 1 Antigen 7 was not observed to cross-react with any of 
the cattle herpesviruses studied. It may be shown to not cross-react with 
other herpesviruses that do not cross-neutralize, due to its association 
with BHV 1 neutralization. If cross-reactions are not found, Antigen 7 
could be used in a BHV 1-specific serodiagnostic test. The use of BHV 1 
Antigen 3 in a BHV 1-infection specific serodiagnostic test requires that 
it not cross-react with other herpesviruses which infect cattle 
nonlethally. Also of interest would be the occurrence of this antigen in 
temperature-sensitive mutants of BHV 1 and SHV 1 at non-permissive 
temperatures. 
Isolation and characterization of many BHV 1 antigens (e.g. 1, 2, 3, 7, 
8 and the "hidden" antigen) would be worthwhile, but Antigens 3 and 7 
warrant special attention. Antigen 3 could be used to test sera from 
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animals vaccinated with inactivated virus (uninfected) and sera from 
infected animals. Observation of a difference between these groups in 
antibody activity against Antigen 3 relative to total activity against 
BHV 1 or against Antigen 7 might then lead to a BHV 1-infection specific 
serodiagnostic test. Antigen 7 could be tested for protective activity, 
contributing to BHV 1 subunit vaccine development. The use of a defined, 
DNA-free BHV 1 protective vaccine might eliminate many of the safety and 
latency problems inherent in the use of less restricted products. If 
Antigen 7 is also shown to be BHV 1-specific, the development of serodiag-
nostic tests based on Antigen 7 and a "complementary antigen" (e.g. Antigen 
3} would allow more certain differentiation between vaccinated and infected 
animals than that allowed by present vaccines. A BHV 1-infection specific 
serodiagnostic test would be extremely valuable in simultaneous 
vaccination-eradication efforts, epidemiologic investigations, and 
certification of animals as free of BHV 1 infection. 
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